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ABSTRACT 
The hematopoietic cytokine Granulocyte/Macrophage Colony Stimulating Factor is 
involved in cognitive processing 
 
Granulocyte/macrophage colony stimulating factor (GM-CSF) is a growth factor originally 
discovered in the hematopoietic system. Recently presence of GM-CSF and its receptor 
(GM-CSFR) was reported on CNS neurons. Here we investigated whether this system is 
involved in cognition by evaluating learning and memory formation in GM-CSF deficient 
(GMko) mice. In a complementary approach, GM-CSF signalling was bidirectionally 
manipulated specifically in the adult hippocampus by adeno-associated virus (AAV) mediated 
GM-CSF receptor α (GM-CSFRα) overexpression or knock-down. In GMko mice, broad 
cognitive deficits were observed in all behavioural paradigms tested. Animals showed 
impairments in fear memory to conditioned cue, in spatial learning in an active place 
avoidance paradigm, and in spatial memory and re-learning flexibility in the Morris Water 
Maze. Additionally, knock-outs also showed diminished exploratory drive. The inferior 
cognitive performance was not due to secondary factors such as motor function, inherent 
anxiety, or pain threshold levels. Corroborating these data, spatial memory of AAV-injected 
mice in the MWM was enhanced or impaired dependent on GM-CSFR alpha overexpression 
or knock-down, respectively. GMko mice showed diminished overall dendritic length and 
branching complexity in the dentate gyrus (DG) and reductions in both dendritic spine density 
and the percentage of mature spines in the hippocampus. Despite these morphological 
alterations and the strong memory deficits, induction of long-term potentiation (LTP) was not 
impaired in the hippocampus of knock-out mice, providing an example for the complicated 
relationship of LTP and memory performance. Collectively, these results suggest that 
GM-CSF signalling plays a major and hitherto unrecognized role in neuronal structural 
plasticity relevant to learning and memory. This finding is of particular therapeutic relevance, 
as GM-CSF readily passes the intact blood-brain barrier. 
ZUSAMMENFASSUNG 
Das hämatopoetische Zytokin Granulozyten/Makrophagen-Kolonie stimulierender 
Faktor ist beteiligt an kognitiver Verarbeitung 
 
Granulozyten/Makrophagen-Kolonie stimulierender Faktor (GM-CSF) ist ein ursprünglich 
aus der Hämatopoese bekannter Wachstumsfaktor, der kürzlich samt seinem Rezeptor 
(GM-CSFR) auch auf Neuronen im Gehirn nachgewiesen wurde. Gegenstand der 
vorliegenden Studie war eine mögliche Beteiligung dieses Systems an kognitiven Prozessen. 
Hierzu wurde die Lern- und Gedächtnisfähigkeit GM-CSF-defizienter (GMko) Mäuse 
untersucht. In komplementären in vivo Experimenten wurde mit Hilfe Adeno-assoziierter 
Virusvektoren (AAV) ausschließlich im Hippocampus adulter Mäuse die neuronale 
Molekülzahl der alpha-Untereinheit des GM-CSF Rezeptors (GM-CSFRα) erhöht oder 
verringert, und so entsprechende Signalwege jeweils aktiviert oder gehemmt. GMko-Mäuse 
zeigten kognitive Defizite in sämtlichen angewendeten Verhaltenstests inklusive verringertem 
Angstgedächtnis für einen konditionierten auditorischen Reiz, geringerem räumlichen Lernen 
in einem Active Place Avoidance Test, sowie verringertem räumlichen Gedächtnis und eine 
geringere Umlernfähigkeit in einem Morris Water Maze (MWM). Zudem zeigten diese Tiere 
reduziertes Explorationsverhalten. Diese Befunde waren unabhängig von möglichen 
sekundären Einflüssen betreffend die Motorik, Ängstlichkeit oder Höhe der Schmerzschwelle. 
Unterstützt werden diese Daten durch Ergebnisse mit AAV-behandelten Tieren, die abhängig 
vom Expressionsniveau des GM-CSFRα im MWM je verbesserte oder verringerte räumliche 
Gedächtnisleistung zeigten. Die zelluläre Gesamtlänge der Dendriten im Gyrus dentatus, 
sowie deren Verzweigungsgrad, waren in GMko-Mäusen geringer, ebenso die hippocampale 
Besatzdichte mit dendritischen Dornfortsätzen sowie die relative Anzahl reifer Dornfortsätze. 
Trotz dieser morphologischen Veränderungen und des Gedächtnisdefizits war die Ausbildung 
von Langzeitpotenzierung (LTP) im Hippocampus nicht beeinträchtigt, was ein Beispiel 
darstellt für die komplizierte Beziehung zwischen LTP und Gedächtnisbildung. Insgesamt 
legen diese Ergebnisse den Schluss nahe, dass GM-CSF eine zuvor unbekannte Rolle in 
neuronalen Plastizitätsvorgängen spielt, die für Lernen und Gedächtnisbildung notwendig 
sind. Dieser Befund hat möglicherweise eine besondere therapeutische Relevanz da GM-CSF 
die intakte Blut-Hirn-Schranke überquert. 
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1 INTRODUCTION 
 
1.1 GM-CSF Biology 
 
1.1.1 GM-CSF and the hematopoietic system 
THE mammalian granulocyte/macrophage colony stimulating factor (GM-CSF) is 
a secretory glycoprotein of 15-35 kDa which was named after its ability to 
generate both granulocyte and macrophage colonies from bone marrow-derived 
hematopoietic progenitor cells in vitro (Metcalf, 1989). Its existence was first 
postulated in the 1960s when it was found that formation of these neutrophilic 
colonies did not occur unless progenitor cells were co-cultured with either cells or 
medium conditioned by cells from other tissues including spleen, kidney, lung, 
uterus, testis, and ovary (Bradley and Metcalf, 1966; Ichikawa et al., 1966; 
Robertson and Seamark, 1992). Hence, a variety of tissues appeared capable to 
generate and secrete this factor (Fig. 1). 
Partly due to the presence of only minute amounts of GM-CSF protein in all of 
these tissues (Hill et al., 1995), however, its biochemical isolation was only 
achieved more than a decade later from the murine lung (Burgess et al., 1977), 
and human GM-CSF was not purified until the mid 1980s (Gasson et al., 1984). 
The subsequent observation that addition of purified GM-CSF to hematopoietic 
progenitor cells was sufficient even in serum-free media to induce formation of 
granulocyte and macrophage colonies revealed that GM-CSF had a direct effect 
on these progenitor cells that did not require intermediate serum factors (Metcalf 
et al., 1980; Hill et al., 1995). 
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Figure 1. GM-CSF is expressed and secreted by a variety of different tissues and cell types 
including but not restricted to lung, muscle, and hematopoietic cells. From (Metcalf, 2008). 
 
However, purification of GM-CSF from tissue did not yield sufficient amounts of 
protein to conduct in vivo studies. This only became possible when both the 
murine and human GM-CSF genes were molecularly cloned (Gough et al., 1984; 
Wong et al., 1985), thus facilitating recombinant GM-CSF (rGM-CSF) expression 
in large quantities. Subsequent studies confirmed a dose-dependent increase in 
granulocyte and monocyte-macrophage counts following repetitive injections of 
rGM-CSF in both mice (Metcalf et al., 1987) and human AIDS patients 
(Groopman et al., 1987). 
Further clinical investigations established GM-CSF as a therapeutic option to 
ameliorate both chemo- and radiotherapy-induced neutropenia and for the 
myeloid recovery after bone-marrow transplantation (Brandt et al., 1988; 
Nemunaitis et al., 1988; Visani et al., 1990; reviewed in Lieschke and Burgess, 
1992). Moreover, GM-CSF was shown to expand the circulating compartment of 
hematopoietic progenitor cells by mobilization of bone marrow stem cells 
(Socinski et al., 1988). This greatly facilitated the harvesting of peripheral blood 
stem cells which could be used as a substitute for bone marrow cells in 
transplantation procedures (Gianni et al., 1989; reviewed in Metcalf, 2008). To 
date, GM-CSF has proven a valuable agent in these indications, and has 
demonstrated an excellent safety and tolerability profile in its 20 years of clinical 
use. 
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Apart from its activity as a regulator of hematopoietic progenitor cell proliferation 
and differentiation, however, GM-CSF is also a key determinant in the functional 
activation of terminal effector cells in the hematopoietic system. For example, a 
large body of evidence indicates GM-CSF to exert tight control over the 
efficiency of antigen presentation by dendritic cells (Sallusto and Lanzavecchia, 
1994), leukocyte chemotaxis and cell-cell adhesion (Arnaout et al., 1986), 
oxidative metabolism and phagocytic activity of neutrophils (Fleischmann et al., 
1986; Weisbart et al., 1987), fungicidal activity of monocytes (Smith et al., 1990), 
and the transition from resting to activated T-lymphocytes (Shi et al., 2006). 
These pleiotropic functions implicate an additional pro-inflammatory role for 
GM-CSF (reviewed in Hamilton, 2008; Hercus et al., 2009). Moreover, by 
controlling both dendritic cell and lymphocyte activity, GM-CSF provides a link 
between the innate and the adaptive immune system. A summary of the various 
effects GM-CSF exerts on different target cell types is shown in Figure 2. 
 
 
Figure 2. GM-CSF is a pleiotropic hematopoietic cytokine. A variety of different cellular 
functions are mediated by GM-CSF in the hematopoietic system including regulation of 
proliferation, lineage commitment, and functional activation of effector cells. After (Metcalf, 
2008).  
 
On the background of combined GM-CSF-regulated leukocyte generation and 
regulation of activity, clinical relevance has been established for GM-CSF in the 
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etiology of both hematopoietic and inflammatory disorders. For example, 
dysregulated GM-CSF signalling plays a central role in the development of 
juvenile myelomonocytic leukemia (JMML), a rare but devastating disease that 
leads to juvenile death in the majority of cases (Chan et al., 2005; Iversen et al., 
1996; Birnbaum et al., 2000). This myeloproliferative disorder is characterised by 
a combination of excessive GM-CSF secretion by transformed hematopoietic 
progenitor cells and a concomitant autocrine hypersensitivity of these cells to this 
cytokine (Yoshida et al., 2009). Rheumatoid arthritis (RA), on the other hand, is 
an autoimmune disease characterized by chronic inflammation of synovial joints, 
synovial hyperplasia, and massive infiltration of lymphocytes, macrophages, 
dendritic cells, and neutrophils into both synovial tissue and fluid. Enhanced 
levels of GM-CSF have been observed in the synovium of RA patients (Jang et 
al., 2006) and blockade of GM-CSF signalling was shown to alleviate RA 
symptoms (Cook et al., 2001; reviewed in Cornish et al., 2009). A third condition 
associated with malfunctions in the GM-CSF system is pulmonary alveolar 
proteinosis (PAP), a lung pathology related to dysfunctional alveolar macrophages 
that is characterized by dysregulated surfactant homeostasis and a subsequent 
accumulation of lipoproteinaceous material in alveoli that renders patients at risk 
of secondary infection and respiratory failure (Seymour and Presneill, 2002). The 
genetic loss of essential GM-CSF signalling components has been linked to 
congenital PAP, while autoimmunity against GM-CSF protein has been shown to 
underlie an idiopathic form of this disorder (Trapnell et al., 2003). In fact, it was 
the phenotypic characterization of a GM-CSF knock-out (GMko) mouse line that 
revealed the central role this cytokine plays in PAP (Dranoff et al., 1994).  
Surprisingly, however, in these GMko mice no effect was observed on the counts 
of bone marrow hematopoietic progenitor cells, peripheral leukocytes, and 
hematopoietic cells in tissues (Dranoff et al., 1994), and these findings were 
confirmed by a different group that generated an independent GMko mouse line 
(Stanley et al., 1994).  Indeed, lethally irradiated GMko mice could be rescued by 
bone marrow transplants from untreated GMko donors (Dranoff et al., 1994). 
While these in vivo findings demonstrated GM-CSF to play an essential role in 
basal lung physiology, unexpectedly, no such impact was detected on basal 
hematopoiesis which appears governed, at least to some extent, by functional 
cytokine redundancy. Hence, the notion that GM-CSF was an essential regulator 
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of basal myelopoiesis in vivo had to be rejected. Rather, a large and growing body 
of evidence now suggests that GM-CSF plays an essential, non-redundant role in 
emergency myelopoiesis after infection where it leads to accelerated neutrophil 
production by hematopoietic progenitors in the bone marrow and to survival and 
activation of this progeny at the site of infection (Zhan et al., 1998; Metcalf, 2008; 
Hercus et al., 2009; Shibasaki et al., 2007; Guthridge et al., 1998). In the course of 
such immune responses, activated T-cells seem to be a main source of GM-CSF 
secretion. 
 
 
1.1.2 GM-CSF receptors, ligand binding, and 
signal transduction pathways 
GM-CSF exerts its biological activities by binding to GM-CSF receptors 
(GM-CSFR) located in the plasma membrane of target cells. These receptors are 
heteromeric complexes consisting of two different subunits: the GM-CSF receptor 
alpha (GM-CSFRα) which confers ligand-specific binding, and a common beta 
(βc) subunit that acts as the signal transduction chain and is shared with the closely 
related receptors for interleukin (IL)-3 and IL-5 (Metcalf, 1989). While βc alone 
does not show any detectable ligand binding activity, GM-CSFRα alone binds 
GM-CSF with low affinity (KD = 0.2-100 nM), but it is only after the ligand-
induced aggregation of GM-CSF:GM-CSFRα complexes with βc that ligand 
binding is converted to a high-affinity state (KD = 100 pM), thus generating a 
stable ternary complex with functional signalling activity (Hoang et al., 1993; 
Hansen et al., 2008). However, one report also indicated that preformed 
GM-CSFRα:βc complexes may exist in the plasma membrane of a human 
leukemic cell line (Woodcock et al., 1997). Notably, abundance of GM-CSFRs in 
the plasma membrane is very low with only 100-1000 molecules per subunit 
(Hansen et al., 2008). Expression of GM-CSFRs has been confirmed in myeloid 
cells, lymphocytes, and a variety of non-hematopoietic cells including endothelial 
cells, small-cell lung carcinoma cells, neurons, and neural stem cells. 
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Both GM-CSFRα and βc are typical single-pass type I transmembrane proteins 
with an extracellular domain, a small transmembrane region, and a cytoplasmic 
tail. They belong to the superfamily of cytokine receptors which is characterized 
by conserved structural features in the extracellular domain such as two conserved 
pairs of cysteine residues that form stable disulfide bridges and thus contribute to 
structural integrity of the polypeptide chain (Guthridge et al., 1998). Moreover, 
they contain a characteristic Trp-Ser-X-Trp-Ser (WSXWS) motif in the 
membrane-proximal region that mediates protein folding and protein-protein 
interaction between membrane-bound cytokine receptors (Rosas et al., 2007). 
Both the cysteines and the WSXWS motif are incorporated into two 
fibronectin III (FNIII) folds containing seven antiparallel β strands each (Bazan, 
1990; Rajotte et al., 1997) designated A-G and A’-G’ for the N- and C-terminal 
folds, respectively. Together, these two FNIII folds form a characteristic cytokine 
receptor module (CRM). While the extracellular region of GM-CSFRα comprises 
one CRM, and hence two fibronectin III domains (αD1, αD2), βc consists of two 
CRMs, and hence four fibronectin III domains (βD1-βD4). 
In GM-CSFRα, the bulk of the 388 amino acids that constitute the whole 
polypeptide are contained within the extracellular domain, while the cytoplasmic 
tail is rather short with a length of only 40 amino acids. This tail contains a 
proline-rich Pro-Pro-X-Pro domain (PPXP) that contributes to signal transduction 
via the βc subunit in functional ligand-receptor complexes (Doyle and Gasson, 
1998), and deletion of the cytoplasmic tail abrogates GM-CSF signalling but has 
no effect on ligand binding (Polotskaya et al., 1993). This structural principle also 
applies for the closely related ligand-specific alpha receptor chains for IL-3 
(IL3Rα) and IL-5 (IL5Rα) whose cytoplasmic tails provide equivalent, yet distinct 
contributions to intracellular signal transduction via the βc subunit, thus explaining 
the overlapping functional effects these cytokines exert on target cells 
co-expressing βc with combinations of GM-CSFRα, IL3Rα, and IL5Rα (Hercus et 
al., 2009; Muto et al., 1995). Apart from that, alternatively spliced soluble 
GM-CSFRα isoforms have been described both in vitro and in vivo, and have 
been shown to modulate GM-CSF bioactivity by scavenging circulating cytokine 
molecules (Brown et al., 1995; Sayani et al., 2000). 
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The cytoplasmic domain of the signal transducing βc subunit is much larger and 
very similar in size to the extracellular domain. Nevertheless, it does not contain 
intrinsic tyrosine kinase or any other enzymatic activity to initiate signal 
transduction. Instead, via two conserved motifs in the juxtamembrane region 
termed Box 1 and Box 2, constitutive binding of Janus kinase 2 (JAK2) is 
achieved, and transphosphorylation of JAK2 molecules upon receptor activation 
initiates intracellular signal transduction via activation of signal transducer and 
activator of transcription (STAT) molecules (Quelle et al., 1994). It has been 
shown recently that the structure of the GM-CSFR complex comprises a 2:2:2 
hexameric assembly of two intertwined βc chains, two GM-CSFRα chains, and 
two GM-CSF molecules (Hansen et al., 2008). However, JAK2 transactivation 
within these hexamers is prevented by a gap of 120 Å between the cytoplasmic 
domains of the two βc chains, a distance too wide to allow enzymatic interaction 
of associated JAK2 molecules. As illustrated in Figure 3, it is only via the 
formation of an unusual dodecamer complex that close association (~ 10 Å) and 
subsequent transactivation of JAK2 molecules is facilitated (Hansen et al., 2008). 
In this configuration, transphosphorylation takes place between JAK2 molecules 
associated with different hexamers. 
 
 
Figure 3. Model for functional activation of GM-CSF receptors. Low-affinity binary 
complexes of GM-CSF-bound GM-CSFRα associate with free βc dimers to form stable 
high-affinity hexameric complexes. Subsequent assembly of hexamers into dodecameric 
complexes is required to facilitate close proximity and transactivation of βc-bound JAK2 
molecules (red circles) of different hexamers, thus inducing intracellular signalling. From (Hansen 
et al., 2008). 
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Extensive structure-function analyses of GM-CSF, GM-CSFRα, βc, and 
ligand-bound receptor complexes led to a detailed understanding of the molecular 
events during ligand binding and receptor complex formation. The structure of the 
127 amino acids GM-CSF ligand has been determined by x-ray crystallography 
which revealed a non-spherical configuration dominated by four α helices 
(Diederichs et al., 1991), a tertiary structure known from other cytokines 
including IL-2, IL-5, and growth hormone (Hercus et al., 1994). In conjunction 
with results from earlier studies (Clark-Lewis et al., 1988; Kaushansky et al., 
1989; Shanafelt et al., 1991) receptor binding could thus be assigned to the first 
and fourth helices of GM-CSF and residues Lys14, His15, Glu21, and Asp112 
were shown to be indispensible for bioactivity of the murine cytokine (Meropol et 
al., 1992; Hercus et al., 1994). Residue Arg280 in the F’-G’ loop of GM-CSFRα 
also plays an essential role in GM-CSFR activation by providing electrostatic 
interaction with Asp112 of GM-CSF (Fig. 4a), and charge reversal mutations of 
Asp112 led to a 1000-fold decrease in receptor binding affinity of the cytokine 
(Rajotte et al., 1997). On the other hand, charge reversal mutations by arginine 
substitution of GM-CSF residue Glu21 (E21R) led to near-complete retention of 
low-affinity binding to GM-CSFRα but abolished formation of high-affinity 
receptors, and hence abrogated stimulation of cellular proliferation and mature 
cell function (Lopez et al., 1992). In fact, E21R was found to act as a dominant 
negative inducer of apoptosis in primary human hematopoietic cells (Iversen et 
al., 1996). From these findings it was deduced that Glu21 plays a crucial role in 
the association of GM-CSF:GM-CSFRα complexes with βc to form stable ternary 
signalling complexes, a notion corroborated by the three-dimensional location of 
Glu21 within the receptor complex (Fig. 4b). 
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Figure 4. Three-dimensional model of GM-CSF binding to its receptor. (Left panel) 
Low-affinity binding is mediated by interaction between the F’-G’ loop of GM-CSFRα (left, 
yellow) and helix D of the GM-CSF ligand (red) through electrostatic interaction between residues 
R280 of the receptor (green) and D112 of the ligand (blue). Other side chains of minor importance 
are shown as well. (Right panel) Three-dimensional model of extracellular portions of a liganded 
GM-CSF receptor complex containing GM-CSF (top), GM-CSFRα with its WSXWS motif (left, 
green), and βc (right). Basic receptor side chains involved in ligand binding are shown in white 
(R280 of GM-CSFRα and H367 of βc) while interacting acidic ligand side chains are shown in 
magenta. Note the interaction of GM-CSF residue E21 with the βc subunit which is required for 
high-affinity binding. From (Rajotte et al., 1997) 
 
This was recently confirmed by high-resolution analysis of isolated βc at 3.0 Å 
(Carr et al., 2001) and 2.7 Å (Carr et al., 2006), and by the crystal structure of 
GM-CSF receptor complexes at 3.3 Å (Hansen et al., 2008) where Glu21 of the 
cytokine was shown to critically interact with Tyr365 and His367 in the B-C loop, 
and with Tyr421 in the F-G loop of βD4 (Fig. 5). Any alanine substitution of these 
three βc residues completely abolished high-affinity GM-CSF binding (Lock et al., 
1994; Woodcock et al., 1994). 
Elucidation of the crystal structure of the GM-CSF receptor complex led to 
detailed models of both hexameric and dodecameric assemblies of GM-CSF 
receptor complexes (Fig. 6). 
 
INTRODUCTION  10 
 
Figure 5. High-resolution model of GM-CSF binding to βc. (Left panel) GM-CSF (blue) bound 
to GM-CSFRα (yellow) interacts with a composite surface provided by two different βc subunits, 
i.e. by domain 1 of one βc chain (green) and domain 4 of the second βc chain (purple). (Right 
panel) Magnification of boxed area in left panel illustrating the critical position of GM-CSF 
residue Glu21 relative to βc residues Tyr365 and His367 in the B-C loop, and Tyr421 in the F-G 
loop of βc, respectively. After (Hansen et al., 2008). 
 
 
 
Figure 6. Structure of the hexameric and dodecameric GM-CSF receptor complexes. 
(Top left) Side view of a GM-CSF receptor hexameric assembly consisting of two molecules of 
GM-CSF (blue), GM-CSFRα (yellow) and βc (green and purple), respectively. Domain names are 
denoted for all molecules. Dashed lines indicate C-terminal anchoring of the receptor chains to the 
membrane. (Top right) Top view on same hexameric assembly. The membrane would lie 
underneath the hexamer but is not shown for enhanced clarity. (Bottom) Top view on dodecameric 
assembly with different hexamers depicted in different shades. N-terminal portions of GM-CSFRα 
are shown as a knob domain for which high quality structural data is missing. A simplified 
illustration of the dodecameric assembly is shown in the lower panel which highlights the relative 
positions of the individual modules. Chains of βc are labelled a-d, chains of GM-CSFRα are 
labelled likewise but start with an α. “D” indicates a domain. After (Hansen et al., 2008) 
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 Apart from the aforementioned JAK/STAT pathway, GM-CSF is known to 
induce at least two other signalling cascades: the mitogen-activated protein kinase 
(MAPK) and the phosphoinositide 3-kinase (PI3K) pathway. These multiple 
pathways are not mutually exclusive but, instead, may overlap to a considerable 
degree and thus contribute to a network signalling response that may help to 
explain the pronounced pleiotropic effects of GM-CSF. 
In JAK/STAT signalling following GM-CSFR activation, JAK2 molecules 
pre-associated with βc subunits of different hexamers transactivate each other and 
subsequently also phosphorylate tyrosine residues in the cytoplasmic tail of βc 
such as Tyr577, Tyr612, Tyr695, Tyr750, Tyr806, and Tyr866 which are 
conserved between mouse and human (Guthridge et al., 1998). These 
phosphotyrosines then provide docking sites for proteins containing 
Src homology 2 (SH2) domains such as members of the STAT family. While 
STAT5 appears to be the predominant member of the STAT family involved in 
GM-CSF signal transduction, isoforms STAT1, STAT3, and STAT6 play 
differentially important roles in a variety of target cell types as well (de Groot et 
al., 1998). Following JAK2-mediated phosphorylation, STATs dimerize to form 
functional transcription factors and subsequently translocate to the nucleus to 
regulate expression of target genes including oncostatin M, and pim-1 (Yoshimura 
et al., 1996; de Groot et al., 1998).  
In parallel, GM-CSF-induced phosphorylation of βc tyrosine residues also triggers 
docking of adaptor proteins Shc and Grb2 to Tyr577 and Tyr612/Tyr695, 
respectively, which leads to activation of these adaptors followed by the formation 
of Shc/Grb2 heterodimers. These dimers, in turn, can activate Ras-GTPase, thus 
triggering the MAPK signalling pathway which leads to activation of different 
members of the MAPK family including ERK1, ERK2, p38, and JNK/SAPK 
(reviewed in de Groot et al., 1998). Indeed, GM-CSF has been shown to rapidly 
induce activation of both Ras and its downstream target c-Raf (Kanakura et al., 
1991; Satoh et al., 1991), as well as phosphorylation of ERK1 and ERK2 
(Schallenberg et al., 2009). The MAPK pathway is likely involved in mediating 
GM-CSF induced proliferation, although cross-talk between signalling cascades 
makes it difficult to fully dissect contributions of individual signalling pathways 
to distinct functional outcomes. 
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Activation of the PI3K pathway is the third major signalling cascade initiated by 
GM-CSF. The heterodimeric, cytosolic PI3K is composed of the regulatory and 
catalytic subunits p85 and p110, respectively, and although the molecular details 
initiating this pathway are less well understood, tyrosine phosphorylation of p85 
seems to play an important role in p110 activation (al-Shami et al., 1997) and 
phosphorylation of βc Tyr577 and Tyr612 may be important in this process, a 
finding that indicates an upstream role for JAK2 (Dijkers et al., 1999). The lipid 
kinase PI3K phosphorylates its plasma membrane-bound substrate 
phosphatidylinositol 4,5-bisphosphate (PIP2) to generate phosphatidylinositol 
(3,4,5)-trisphosphate (PIP3) to which the PI3K downstream effector 
phosphoinositide dependent kinase 1 (PDK1) can subsequently bind via its 
pleckstrin homology (PH) domain. PDK1 acts as a master regulator of several 
downstream kinases including p70 ribosomal S6 kinase (S6K), p90 ribosomal S6 
kinase (RSK), serum and glucocorticoid-induced protein kinase (SGK), several 
isoforms of protein kinase C (PKC), and Akt (for review see Bayascas, 2008), 
with the latter appearing as the most significant for GM-CSF function (Perugini et 
al., 2010; Guthridge et al., 1998). Signalling via Akt, also known as 
protein kinase B, has potent anti-apoptotic effects that contribute to cytokine-
induced survival of target cells. These protective effects of the serine/threonine 
kinase Akt are partially mediated via phosphorylation-induced inactivation of the 
pro-apoptotic protein BAD, an inhibitor of anti-apoptotic Bcl-2 family members, 
and further Akt-related survival signals are transmitted by direct activation of IκB 
kinase (IKK) leading to disinhibition of transcription factor NFκB, and hence to 
expression of a variety of pro-survival genes. Moreover, there is additional 
evidence that activated GM-CSFRs can bind IKK directly via GM-CSFRα, and 
hence activate NFκB signalling in a more direct way (Ebner et al., 2003). 
 
 
1.1.3 GM-CSF in the central nervous system 
Apart from its functions in the hematopoietic system, GM-CSF has also been 
shown to exert effects on cells in the central nervous system (CNS). For example, 
an early study on primary glial cells revealed the presence of functional 
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GM-CSFRs in plasma membranes of oligodendrocytes (Baldwin et al., 1993). 
Later reports demonstrated neuromodulatory effects of peripherally applied 
GM-CSF such as indirect inhibition of scopolamine-induced anterograde amnesia 
(Bianchi et al., 1996), regulatory actions on hypothalamic levels of glutamate and 
GABA neurotransmitters (Bianchi et al., 1997), and modulatory effects on the 
electrical activities of both the medullary gigantocellular reticular formation in the 
CNS and the efferent splenic nerve in the peripheral nervous system (Lukashenko 
et al., 2004). Moreover, centrally administered GM-CSF was shown to induce 
somnogenic effects with impacts on both rapid eye movement (REM) sleep and 
non-REM sleep in rats (Kimura et al., 2000) and also to decrease food intake and 
body weight in both rats and mice (Reed et al., 2005). 
A study by McLay and co-workers revealed that GM-CSF is able to cross the 
intact blood-brain and blood-spinal cord barriers by means of a selective and 
saturable transport system, thus providing initial explanation for the observed 
central effects (McLay et al., 1997) after peripheral application of GM-CSF. In 
extension to this, both GM-CSF and GM-CSF receptor expression was found in 
neurons and neural tissues in the developing human fetus at 8 and 16 weeks 
postconception (Dame et al., 1999). 
Respective expression data for the adult mammalian CNS, however, was only 
recently obtained in a study by Schäbitz and colleagues which demonstrated 
constitutive co-expression of both GM-CSF and GM-CSF receptor in the CNS by 
the neuronal subpopulation (Schabitz et al., 2008). This endogenous expression of 
GM-CSF indicates that the CNS is independent, to some extent, from influx of 
peripherally produced GM-CSF via the blood-brain barrier, and further suggests 
an autocrine mode of action in the healthy brain. This study also revealed 
selective upregulation of both GM-CSF and GM-CSFRα under conditions of 
experimental ischemic stroke and demonstrated infarct volumes to be reduced 
after GM-CSF application. Induction of Akt signalling was shown to contribute to 
this neuroprotective mechanism (Schabitz et al., 2008). These functional 
outcomes were confirmed by an independent study also using a middle cerebral 
artery occlusion rat model (Kong et al., 2009). Neuroprotective effects were also 
observed in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced 
murine model of Parkinson’s disease where subcutaneous application of GM-CSF 
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promoted survival of dopaminergic neurons in the substantia nigra and partially 
rescued the MPTP-induced locomotor deficit (Kim et al., 2009). 
Beneficial central effects of GM-CSF were additionally demonstrated in rodent 
models of spinal cord injury (SCI) where GM-CSF provided anti-apoptotic 
neuroprotection in a spinal cord contusion model (Ha et al., 2005), inhibited glial 
scar formation (Huang et al., 2009), and activated neural stem/progenitor cells in 
the injured spinal cord (Hayashi et al., 2009). 
Additional in vitro studies further suggest that GM-CSF also induces proliferation 
of neural stem cells (Kim et al., 2004) and subsequently drives their 
differentiation into neurons (Kruger et al., 2007), thus indicating positive effects 
on neuronal plasticity for this cytokine. Apart from its neuroprotective functions, 
GM-CSF consequently appears to mediate some degree of neuronal replenishment 
and induction of brain plasticity in the CNS under disease conditions, and hence 
to exert beneficial effects in a dual mode. 
Nevertheless, only scarce information exists regarding the role of GM-CSF in the 
healthy brain. In particular, virtually no information is available on the impact of 
neuronal GM-CSF signalling on learning and memory, despite the constitutive 
neuronal co-expression of GM-CSF and GM-CSFR in a wide variety of brain 
regions including cortex and hippocampus (Schabitz et al., 2008). While a recent 
report has shown reversal of cognitive deficits in a mouse model of Alzheimer’s 
disease (AD) after GM-CSF application, the authors related this effect to a 
GM-CSF-induced reduction in amyloidosis. The ability of GM-CSF to regulate 
Aβ levels both in vitro and in the brains of a transgenic AD mouse model has also 
been shown previously (Volmar et al., 2008; Manczak et al., 2009). Hence, it 
remains unknown whether GM-CSF signalling in the brain exerts genuine 
neuronal actions that affect learning, memory, and an animal’s ability to process 
complex information. 
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1.1.4 Other hematopoietic factors in the brain 
Hematopoietic GM-CSF is functionally related to the cytokines 
granulocyte-colony stimulating factor (G-CSF) and erythropoietin (EPO) although 
these proteins do not share any considerable sequence homology. Like GM-CSF, 
both other cytokines are heavily glycosylated in vivo and bind to cytokine type I 
receptors (G-CSFR and EPOR, respectively) located in the plasma membranes of 
target cells. They act as growth factors on myeloid lineage stem cells in the 
hematopoietic system and induce proliferation and subsequent differentiation into 
the various effector cell types after which they were named, respectively. 
In recent years, however, additional important functions in the CNS have been 
assigned to these well-known hematopoietic factors, and receptors for all three 
cytokines have recently been demonstrated in the brain (Digicaylioglu et al., 
1995; Schneider et al., 2005; Schabitz et al., 2008). It has been suggested that 
these cytokines exert important neurotrophic functions by employing basal 
cellular mechanisms similar to those in the blood (for review see Maurer et al., 
2008; Tonges et al., 2007). Indeed, enhanced adult neurogenesis has been 
described for EPO (Shingo et al., 2001; Wang et al., 2004), G-CSF (Schneider et 
al., 2005), and GM-CSF (Kruger et al., 2007), and it is interesting to note that a 
comparison of gene expression profiles between neural and hematopoietic stem 
cells has revealed a high degree of similarity (Terskikh et al., 2001). 
Similar to GM-CSF, neuroprotective actions with beneficial effects in a variety of 
neurodegenerative diseases have been established for both EPO and G-CSF in 
rodent models for stroke (Schabitz et al., 2003; Wang et al., 2004), amyotrophic 
lateral sclerosis (Grunfeld et al., 2007; Henriques et al., 2011; Pitzer et al., 2008) 
and Parkinson’s disease (Ganser et al., 2010; Kim et al., 2009; Meuer et al., 
2006). Hence, all three factors present potential clinical options in neurological 
conditions, particularly in light of their ability to cross the blood-brain barrier, 
thus facilitating peripheral application (McLay et al., 1997; Brines et al., 2000; 
Schneider et al., 2005). 
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1.2 Cognition and the Hippocampal Formation  
 
1.2.1 Facets of cognition and memory 
Cognition is a broad term describing a variety of mental activities associated with 
the neural processing of information. These activities include aspects of 
perception, learning, memory, association, judgment, thinking, reasoning, 
knowing, problem-solving, planning, imagination, and language, and hence some 
of the frequently cited but ill-defined higher functions of the brain. As some of 
these mental processes are inextricably linked to conscious experience for which 
non-linguistic behavioural indexes are missing, their existence remains elusive in 
non-human animals, and hence not all of these aspects are amenable to 
experimental testing in rodents (Griffiths et al., 1999; Eichenbaum, 1997). Of 
those who are, learning and memory are by far the most prominent subjects of 
investigation in cognitive neuroscience. 
In general, different types of memory systems exist in parallel. Some of them may 
be specific to humans, and are governed by different brain regions. The first level 
of discrimination between memory systems is merely based on the time span of 
information storage, and hence the categories are short-term or working memory 
on the one hand and long-term memory on the other. The latter is further 
subdivided by the capacity to access its content consciously into non-declarative 
(not consciously accessible) and declarative (consciously accessible) memory and 
further subdivisions exist within each group (Fig. 7). Despite its frequent and 
widespread use, however, this classification system has also been challenged 
recently (Henke, 2010). 
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Figure 7. A classification system for subtypes of long-term memories. The first level of 
discrimination classifies long-term memories into declarative or non-declarative memory 
depending on whether its content is consciously accessible (declarative memory) or not 
(non-declarative memory). Declarative memory consists of episodic and semantic memory 
systems which store personal, autobiographical experiences and impersonal, factual knowledge 
about the world, respectively, and is highly dependent on medial temporal lobe structures. 
Non-declarative memory comprises procedural learning, priming, classic conditioning, and 
sensitization which are explained in the main text. All subtypes of non-declarative memory appear 
predominantly governed by brain regions other than the medial temporal lobe. From (Henke, 
2010) 
 
Non-declarative or implicit memory comprises several types of memory including 
procedural memory, priming, classic conditioning, and sensitization, and its 
existence is uncontroversial in non-human mammals including rodents. The term 
procedural memory, describes the ability to execute a practiced set of procedures, 
mostly movements, without a need and mostly without a possibility for conscious 
control. Examples include playing an instrument, walking, reading, or swimming. 
This type of long-term memory is often a result of motor learning (Kelley et al., 
2003). Priming is another form of non-conscious memory which describes the 
enhanced ability of a subject to either recognize an item or discriminate between 
different items following a previous encounter with identical or similar items. 
This effect is based on activation of context information in the brain by the 
priming stimulus (Tulving and Schacter, 1990; for review see Schacter et al., 
2004). Classic conditioning refers to a kind of associative memory that mentally 
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links two stimuli based on their repetitive co-appearance in the past in such a way 
that one of these stimuli alone elicits behavioural responses that are typical for the 
other. This type of memory was discovered by the Russian physiologist Ivan 
Pavlov (Pavlov, 1927). Finally, sensitization describes a non-associative form of 
memory eliciting increasing response intensities to repetitive administration of a 
stimulus. This is exemplarily illustrated by the hyperlocomotor behaviour 
observed in subjects after frequent abuse of amphetamines which modulate 
mesolimbic dopamine transmission (Ujike and Sato, 2004). 
The term declarative or explicit memory, on the other hand, refers to those types 
of memories which can be consciously recalled, and which may thus be 
human-specific to some extent. Declarative memory contains two subcategories, 
namely episodic and semantic memory. Episodic memory is defined as a 
repository for autobiographical experiences that stores memories of personally 
experienced events including their multi-faceted spatio-temporal and emotional 
contexts (Tulving and Markowitsch, 1998), and this type of memory appears to 
exist in rodents (Henke, 2010). Semantic memory, on the other hand, comprises 
factual knowledge about the world that is not directly related to personal 
experience, and is widely believed to be a human-specific trait. While, for 
example, remembering having chicken for dinner last Wednesday is episodic 
memory, knowing that chickens are birds which are a group of animals that lay 
eggs and derived from reptiles during evolution is semantic memory. 
One of the best-studied types of memory in rodents is spatial memory which 
describes the ability of an animal to know about its location in a familiar 
environment and, particularly, to navigate it in a goal-directed manner by using 
both self-centered (idiothetic) and external (allothetic) cues for orientation. Spatial 
memory does not fully fit in any of the aforementioned groups as it appears to 
comprise components of both implicit and episodic memory, and two competing 
hypotheses are actively debated to explain the mode of action underlying spatial 
memory, namely the cognitive map hypothesis and the relational memory 
hypothesis (Eichenbaum et al., 1999; Redish, 2001; Kumaran and Maguire, 2005). 
The cognitive map hypothesis originally proposed by Edward Tolman assumes 
the existence or construction of an internal coordinate system into which external 
cues may be integrated and used for orientation (Tolman, 1948; O'Keefe and 
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Nadel, 1978). This hypothesis has received important corroboration through a 
seminal study by O’Keefe and Dostrovsky whose in vivo electrophysiological 
recordings in behaving rats demonstrated that distinct neurons display action 
potential firing patterns that highly correlate with an animal’s position and 
orientation in a test arena (Fig. 8). Individual neurons of this type, whose 
existence was more recently confirmed in the human brain as well (Ekstrom et al., 
2003), displayed high firing rates at certain locations, and reduced or no firing 
activity after the animal changed its position or orientation relative to the external 
cues. These cells were hence termed “place cells” as they appeared to encode the 
occupancy of a specific location in space which was correspondingly termed a 
“place field” (O'Keefe and Dostrovsky, 1971). Interestingly, once these firing 
patterns are established in a given environment, place cells maintain these patterns 
even in the subsequent absence of landmarks (O'Keefe and Speakman, 1987) and 
in the dark (Quirk et al., 1990). It appears very tempting to correlate this 
independence of acute presence of external cues with spatial memory formation. 
 
 
Figure 8. Place cells as location detectors. (Left panel) Schematic representation of a rat in a 
recording stand where hippocampal electrical activity was recorded in vivo. Letters A-H denote 
animals’ positions and orientations in which electrical activity was recorded. (Right panel, top) 
Continuous firing frequency histogram illustrating firing activity of a particular recording unit at 
A-H. Note that this unit was fully active only when rats faced position A or B, and was active to a 
lesser extent when animals were moved from B to D, a process represented by letter C. This unit 
was also weakly active in position H indicating the importance of both position and direction. 
(Right panel, bottom) Raw data recorded at time points 1 and 2 in the upper panel illustrating high 
(1) and low (2) firing activity, respectively, in the particular recording unit. Reference bar, 400 ms. 
After (O'Keefe and Dostrovsky, 1971) 
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These findings received further important refinement through experiments 
showing that place fields are preferentially formed near locations that provide a 
high degree of spatial information, rather than being formed comprehensively all 
over the Cartesian plane. Furthermore, information about the relative distances 
between these saliently cued spots appears neurally encoded in connections 
between place cells, which may thus serve as anchors to which the cognitive map 
is aligned (Hetherington and Shapiro, 1997). 
However, such findings highlighting the non-continuous, non-homogeneous 
character of spatial representation paved the way for a competing relational 
memory hypothesis which essentially assumes spatial memory as a consequence 
of associative memories that were formed during previous encounters with a 
given coordinate in the environment (Eichenbaum, 2000). Spatial memory is 
hence understood as a by-product of overlapping representations of 
cue-configurations associated with neighbouring coordinates (Fig. 9). According 
to this view, location-specific firing of place cells would represent the recognition 
of a certain configuration that is associated with multimodal experiences in the 
past, instead of being merely a gauge for geometric properties of space 
(Eichenbaum et al., 1999).  
 
A B
 
Figure 9. Cognitive map hypothesis versus relational memory coding. (A) According to the 
cognitive map hypothesis, sensory information is integrated into a mental coordinate system which 
provides an animal with an internal spatial map. (B) The relational memory hypothesis assumes 
spatial memory to emerge as a by-product of associative memory through overlapping 
representations of distinct cues with different but overlapping sets of relational information 
content. After (Eichenbaum et al., 1999) 
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While such fundamental aspects of spatial memory currently remain a matter of 
active investigation, it is uncontroversial that the hippocampus is a key brain 
region in this process, with one argument being that place cells appear to be 
exclusively found among the population of hippocampal pyramidal neurons. 
 
 
1.2.2 Structure and function of the hippocampal formation 
The bilateral hippocampal formation is part of the limbic system, a set of 
evolutionarily primordial mammalian brain structures, and is physically located in 
the medial temporal lobes nestled between the brainstem and the neocortex 
(Fig. 10). 
 
 
Figure 10. Anatomy of the brain. (Left panel) The cerebral cortex consists of four major lobes. 
Cerebellum and brain stem structures are shown as well. (Right panel) The limbic system 
comprises several brain structures including the hippocampus and is located between the brain 
stem and the cerebral cortex. (The medical illustrations are provided courtesy of Alzheimer's 
Disease Research, a program of the American Health Assistance Foundation. 
© 2011 http://www.ahaf.org/alzheimers) 
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Its functional roles include the integration of sensory information to generate a 
singular and coherent perception of the environment and the temporal sequence of 
events (Sweatt, 2004), thus acting as a real-time integrator of information. Closely 
linked to this function, the hippocampus also plays a key role in the retrieval of 
previously formed memories, in the updating of these memories by integration of 
novel information, and in the subsequent re-consolidation or initial consolidation 
of adjusted and novel memory traces, respectively. Hence, the hippocampus 
determines and initiates the formation of stable long-term memories from instable 
memory traces, and can thus be regarded as the mammalian brain structure most 
prominently and directly involved in the storage and maintenance of complex 
memory (Kandel, 2001). 
At the structural level, the hippocampal formation presents as a highly organized 
array of neuronal cells which constitute two main substructures, i.e. the cornu 
ammonis (CA) or hippocampus proper consisting of densely packed pyramidal 
cell bodies and the dentate gyrus (DG) consisting of densely packed small granule 
cell bodies. Moreover, the hippocampal formation comprises the entorhinal 
cortex (EC) and the subicular complex which connects the CA1 subfield of the 
hippocampus proper with the EC. The extraordinary degree of organization within 
the hippocampal formation is not restricted, however, to the localization of cell 
bodies, but extends to the network level where specific axonal projections exist 
between individual subregions. Particularly, the hippocampal formation contains a 
characteristic information relay and processing circuit encompassing a tri-synaptic 
pathway that grossly defines the overall signal flow path through the 
hippocampus. As shown in Figure 11, the bulk of incoming signal is transmitted 
from layers II and III of the EC to the DG via axonal projections of the perforant 
path (PP), although minor branches of the PP also feed into all four CA subfields 
(CA1-CA4), and a distinct projection, the temporoammonic pathway, leads 
directly from the EC to CA1 (Deng et al., 2010). Information transmitted from the 
EC has been pre-processed in cortical areas and includes both sensory information 
of various modalities and information about ongoing cognitive processes. In the 
DG, information is relayed to CA3 neurons via non-myelinated axons termed 
mossy fibers that traverse the hilar region. The CA3 target neurons then form the 
third synapse in this tri-synaptic pathway on CA1 pyramidal neurons to which 
they project the efferent Schaffer collateral bundle of axons. The flow of 
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information is subsequently closed to form a circuit via projections from CA1 
pyramidal neurons back to the EC, partially via the subicular complex which, in 
addition, also receives direct input from the EC that has not passed through the 
tri-synaptic pathway. Additional CA1 projections also feed fully processed 
information into the lateral septum, amygdala, and cortical regions, thus providing 
integrated output signals to other brain areas (Sweatt, 2004). 
 
 
Figure 11. Hippocampal circuitry. (Upper panel) Gray arrows denote the classical tri-synaptic 
hippocampal pathway through the DG-CA3-CA1 subfields. The bulk of signal enters the 
hippocampus via axonal projections of the perforant pathway connecting EC layer II with the DG 
which relays processed signal via mossy fibres to CA3 pyramidal cells. These, in turn, project to 
CA1 neurons via the Schaffer collateral bundle of axons. Processed signal is subsequently returned 
to the EC, albeit to deeper layers. In parallel to this circuit, the PP, which splits into lateral (LPP) 
and medial (MPP) portions, also feeds directly into the CA3 subfield, and CA1 receives direct 
input from EC layer III via the temporoammonic pathway. (Lower panel) Simplified model 
illustrating flow of information within the hippocampal formation. From (Deng et al., 2010) 
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Early evidence for a specific and important role of the hippocampus in memory 
formation came from a seminal study by Scoville and Milner who observed severe 
memory deficits in patients after bilateral mesio-temporal lobectomy that included 
the anterior two thirds of the hippocampus to alleviate severe and recurrent 
epileptic seizures resistant to anticonvulsant therapy (Scoville and Milner, 1957). 
The most famous of these, patient HM, exhibited severe and permanent global 
anterograde amnesia following surgery that virtually abolished HM’s ability to 
acquire novel episodic memories in the 55 years between surgery and his death in 
2008 (Milner et al., 1968; Corkin, 1984; for review see Corkin, 2002). Retrograde 
amnesia extending to a limited period of time prior to surgery was also apparent in 
HM. These observations indicated that the ablated aspects of the medial temporal 
lobes (MTLs) including the hippocampus were highly relevant for the formation 
of novel memories, and that ablation probably prevented proper consolidation of 
novel memory traces. However, the partial MTL ablation did not appear to 
interfere with memories that were already firmly consolidated at the time of 
surgery since childhood memories were spared. In line with a specific memory 
consolidation problem, short-term memory was unimpaired in HM (Sullivan and 
Sagar, 1991; Corkin, 2002). 
The paramount role the hippocampus plays in memory formation has later been 
confirmed in non-human primates and rodents where hippocampal lesions of 
varying extent were shown to impair spatial learning and memory, particularly 
when dorsal aspects of the hippocampus were lesioned (Zola-Morgan and Squire, 
1990; Moser et al., 1993; Moser et al., 1995). Since this body of evidence strongly 
indicates the hippocampus to be primarily, maybe uniquely, involved in several 
aspects of memory, experimental manipulations of the hippocampus in animal 
models render mnemonic functions amenable to analysis by behavioural 
assessment in hippocampus-dependent tasks under laboratory conditions. 
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1.2.3 Molecular determinants of hippocampus-dependent 
spatial memory 
Today, through application of pharmacological and genetic engineering 
techniques, the investigation of hippocampus-dependent learning and memory has 
reached the molecular level. These efforts spawned a long and growing list of 
gene products that act as mediators of long-term memory formation both in mice 
and men, and a compilation of these genes is publicly accessible via a curated 
database hosted by the Genes to Cognition programme (G2C) centered at the 
Wellcome Trust Sanger Institute, Cambridge, UK (Croning et al., 2009). Of note, 
however, the G2C compilation focuses on synaptically expressed proteins and 
may thus be intrinsically non-comprehensive, although synaptical processes are 
undoubtedly essential for the structural and functional plasticity events underlying 
memory formation. While cognitive deficits are frequently observed as a 
consequence of dysfunctional learning and memory-related gene products, the 
opposite, cognitive enhancement following increased gene product activity, is 
found less commonly. This particularly interesting subgroup of genes has been 
surveyed in a recent review which listed the few dozens for which transgenic 
mouse models with enhanced cognitive abilities have been reported (Lee and 
Silva, 2009). 
In general, the bulk of learning and memory-related gene products appear to be 
mediators of synaptic plasticity, an activity-dependent process that affects both 
the strength and efficiency of cell-cell communication by inducing structural 
remodelling of the synaptic connection between neurons. However, transcription 
factors regulating the abundance of such effector proteins are clearly important 
players in the context of memory formation as well. To exemplify this, three 
prominent members of fundamentally different protein families shall be briefly 
discussed here for illustration, i.e. the N-methyl-D-aspartate (NMDA) type 
glutamate receptor as a membrane receptor / ion channel, the cAMP response 
element binding protein (CREB) as a transcriptional regulator of long-term 
memory-related gene expression, and the brain-derived neurotrophic factor 
(BDNF) as a member of the nerve growth factor family of proteins.  
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The NMDA subtype of ionotropic glutamate receptors in the postsynaptic 
membrane plays a central role in the neurobiological mechanisms mediating 
certain types of long-term memory formation (reviewed in Riedel et al., 2003). 
These ion channels, which facilitate charge transfer by Na+, K+, and Ca2+ 
conductance, are unique in their combined ligand and voltage-dependent gating 
mechanism that requires binding of glutamate neurotransmitter and concomitant 
membrane depolarization to remove a Mg2+ block from the channel pore, thus 
rendering the receptor a coincidence detector for pre- and postsynaptic activity 
(Seeburg et al., 1995). As such, the NMDA receptor appears as a formidable 
molecular correlate for Hebb’s postulate that learning relies on the enhancement 
of synaptic efficacy between simultaneously activated neurons. This 
heterotetrameric receptor is composed of two obligatory NMDA receptor 1 (NR1) 
subunits and two of six known regulatory subunits comprising four NR2-type 
(NR2A-NR2D), and two NR3-type (NR3A, NR3B) isoforms (Seeburg, 1993; 
Ciabarra et al., 1995; Yashiro and Philpot, 2008). Every specific subunit 
combination endows the holoreceptor with unique overall functional properties by 
influencing its channel kinetics and ion conductance characteristics, and hence the 
receptor’s ability to mediate synaptic plasticity. 
Particular attention has been paid to the two predominant regulatory NMDAR 
subunits NR2A and NR2B which are widely expressed throughout the 
mammalian brain. Here, an interesting differential developmental regulation 
pattern has been found which involves a general shift from low to high ratios of 
synaptic NR2A versus NR2B expression as the animal progresses from perinatal 
to juvenile and adult stages of ontogeny (Monyer et al., 1994; Gambrill and 
Barria, 2011). Hence, while NR2B dominates the early phases of postnatal 
development NR2A becomes more important during later stages. The study by 
Monyer and co-workers also established longer excitatory postsynaptic potentials 
(EPSPs) in recombinant NR1/NR2B compared to NR1/NR2A di-heteromers 
(Monyer et al., 1994). In agreement with this, overexpression of NR2B in the 
murine forebrain of the transgenic Doogie mouse line was found to prolong 
NMDA receptor channel opening, and hence the time window for charge transfer 
and coincidence detection (Tang et al., 1999). Strikingly, these mice displayed 
superior cognitive abilities when compared to age-matched adult wildtypes, thus 
implying the developmental shift from NR2B to NR2A expression as a possible 
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explanation for the decline of memory performance observed in adult mammals. 
A more recent study further indicated that the developmental shift in favour of 
NR2A likely led to increased formation of NR1/NR2A/NR2B tri-heteromers 
rather than to a higher preponderance of NR2A- over NR2B-containing 
di-heteromers (Rauner and Kohr, 2011). 
While the body of evidence implicating NMDA receptor signalling as a key 
determinant of memory formation is much larger, it shall suffice to mention that 
the genetic knock-out of the murine NR2A subunit led to severe impairments of 
both spatial learning abilities and induction of long-term potentiation (Sakimura et 
al., 1995), and that both effects were confirmed by specific pharmacological 
blockade of NMDA receptors (Bannerman et al., 1995). Moreover, spatial 
memory consolidation was elegantly demonstrated to critically depend on the 
presence of the NR1 subunit in the hippocampal CA1 subfield. By genetic 
engineering, Shimizu and colleagues were able to reversibly switch NR1 
expression on and off in the CA1 field during the memory consolidation phase 
(Shimizu et al., 2000). However, while deficiency for NR2B in the forebrain was 
associated with electrophysiological abnormalities and specific memory deficits in 
adult conditional knock-outs, hippocampus-specific NR2B ablations did not 
significantly affect long-term spatial memory formation (von Engelhardt et al., 
2008). This latter finding might indicate that the hypothesis of hippocampal 
NMDA receptor-mediated facilitation of long-term memory formation may need 
some careful adjustment to fully accommodate all relevant experimental results. 
At the molecular level, NMDA receptors are closely associated at their 
intracellular side with a multiprotein complex called the postsynaptic density 
which provides a scaffold for downstream signalling molecules on the one hand, 
but also regulates NMDA receptor stability, function, subunit shuttling and 
composition on the other (van Zundert et al., 2004). While the NMDA 
receptor-mediated inward and outward currents of Na+ and K+, respectively, 
predominantly affect the neuronal membrane potential, Ca2+ influx provides 
additional important functions by triggering intracellular signal transduction 
cascades which ultimately facilitate synaptic remodelling and nuclear adaptations 
in gene expression. One important transducer of NMDA receptor signalling is the 
Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII) which has been 
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shown to bind the C-terminal domain of the NR2B subunit (Bayer et al., 2001; 
Bayer et al., 2006). Interestingly, this domain has previously been shown to be 
important in all NR2 subunits, but only truncation of NR2B led to perinatal 
lethality (Sprengel et al., 1998). 
The CaMKII pathway also links NMDA receptor signalling to activation of 
transcription factor CREB by CaMKII-mediated phosphorylation of CREB 
residue Ser133 (Sheng et al., 1991). CREB has received particular attention in 
memory research since it was found to act as a master regulatory switch for 
long-term memory formation across phyla including molluscs (Dash et al., 1990), 
insects (Yin et al., 1994; Perazzona et al., 2004), and mammals (Barco et al., 
2002). Upon Ser133 phosphorylation-dependent activation in neurons, CREB 
induces expression of target genes required for long-term facilitation, a protein 
synthesis-dependent process involving stable enhancement of synaptic 
transmission (Casadio et al., 1999), by regulating expression of target genes 
through binding to regulatory DNA elements termed cAMP response elements 
(CREs). In line with this, CREB-hypomorphic mice were profoundly impaired in 
both contextual and cued fear conditioning, as well as in spatial long-term 
memory, but not short-term memory formation (Bourtchuladze et al., 1994). The 
fear memory deficits could be completely rescued in these animals, however, 
when CREB was provided in trans to neurons of the lateral amygdala (Han et al., 
2007), thus highlighting the acute need for CREB in this context. Moreover, 
Han and colleagues further showed that participation of individual neurons in the 
process of consolidation of a fear memory trace depended on their respective 
CREB expression levels at the time of fear acquisition (Han et al., 2007). Fear 
memory consolidation impairments were also noted in a transgenic mouse line 
expressing a dominant-negative CREB mutant (S133A) in an inducible, 
tamoxifen-dependent manner (Kida et al., 2002). Furthermore, enhanced 
excitability of CA1 pyramidal neurons has been demonstrated in transgenic mice 
that ectopically express a constitutively active form of CREB (VP16-CREB) 
specifically in these cells (Lopez de Armentia et al., 2007). 
As a transcription factor, CREB mediates its effects indirectly by regulating 
expression levels of target genes including other transcription factors like c-fos 
and zif268 which mediate expression of genes involved in synaptic plasticity 
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(Sheng et al., 1990; Sakamoto et al., 1991), the alpha subunit of CREB-activating 
Ca2+/calmodulin-dependent kinase II  (Olson et al., 1995), and neurotrophins like 
BDNF which modulate synaptic activity (Tao et al., 1998).  
Among the neurotrophic factors which also include nerve growth factor (NGF) 
and glial cell line-derived neurotrophic factor (GDNF), BDNF plays a particularly 
important role in learning and memory formation as evidenced by the substantial 
impacts on these systems associated with manipulations of BDNF function. For 
example, BDNF-deficient mice were shown to be severely impaired in synaptic 
transmission and induction of long-term potentiation (Korte et al., 1995), and both 
effects could be rescued when BDNF was subsequently provided in trans (Korte 
et al., 1996). Moreover, BDNF was shown to enhance synaptic responses to 
high-frequency stimulation in both the early postnatal and adult rat hippocampus, 
and to be indispensible for the induction of LTP (Figurov et al., 1996). At the 
behavioural level, severe spatial memory deficits were found in a conditional 
knock-out mouse line in which the BDNF gene was ablated specifically in the 
hippocampus of adult animals (Heldt et al., 2007), and it was shown that BDNF 
signalling is required within 12 hours after acquisition of a learning task to 
facilitate long-term memory formation (Bekinschtein et al., 2007). Moreover, 
hippocampus-dependent contextual learning was shown to cause a rapid increase 
in BDNF transcript levels in the rat hippocampus (Hall et al., 2000), and 
antibody-mediated scavenging of BDNF molecules in the adult rat brain led to 
impaired spatial learning and memory (Mu et al., 1999).  
This neurotrophin exerts its functions by binding to the transmembrane tyrosine 
receptor kinase B (TrkB), to which at least three important intracellular signalling 
cascades are coupled, i.e. the Ras-MAPK pathway, the PI3K-Akt pathway, and 
the phospholipase Cγ-Ca2+ pathway, all of which may contribute to memory 
formation to some extent (reviewed in Minichiello, 2009). Remarkably, binding 
of BDNF to TrkB leads to rapid depolarization of target cells by Na+-influx on a 
timescale comparable to glutamate receptor activation (Kafitz et al., 1999), thus 
BDNF function clearly encompasses more than mere synapse-to-nucleus signal 
transduction.  
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1.3 Adeno-associated Virus 
 
1.3.1 Basic virology of adeno-associated virus 
Adeno-associated virus (AAV) was originally discovered more than 40 years ago 
as a contamination in adenovirus preparations from cultured rhesus monkey 
kidney cells (Atchison et al., 1965) and was also isolated from human tissue 
shortly after (Blacklow et al., 1967). It was noted very early that these 
parvoviruses were inherently replication-deficient and required superinfection 
with either adenovirus or herpes simplex virus to provide essential helper 
functions for propagation (Hoggan et al., 1966; Conway et al., 1997). Due to this 
characteristic and previously unknown feature, AAV was classified as a unique 
genus termed dependovirus within the Parvoviridae family. In the absence of 
superinfection with a helper virus, wildtype AAV is able to establish latency 
which, in the human genome, occurs specifically by integration at a site termed 
AAVS1 physically located on chromosome 19 at 19q13.4 (Kotin et al., 1990). A 
murine AAVS1 homologue was more recently discovered on chromosome 7 in a 
region syntenic with human chromosome 19 (Dutheil et al., 2004). However, no 
apparent pathogenicity is associated with AAV infection since AAV was never 
related to any disease symptoms despite high infection rates as indicated by a 
prevalence of antibodies against AAV in approximately 80 % of the human 
population (Erles et al., 1999). The immune response to AAV infection appears to 
involve only negligible amounts of cytotoxicity and seems more limited to the 
production of neutralizing antibodies (Hernandez et al., 1999). 
With no more than 25 nm in diameter, AAV is a very small, non-enveloped virus 
that packages a linear single-stranded DNA (ssDNA) genome of approximately 
4.7 kb. Individual virions are packed with a ssDNA of  either (+) or (-) polarity 
such that double-stranded DNA (dsDNA) can form after host cell infection by 
annealing of complementary DNA strands from different virions (Crawford et al., 
1969; Rose et al., 1969). However, the majority of dsDNA after infection is 
generated by replication which, given the existence of (+) and (-) oriented ssDNA, 
requires initiation at both ends of the genome. The underlying mechanism for this 
was found to include inverted terminal repeats (ITRs) of 145 nucleotides which 
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facilitate hairpin loop formation via palindromic sequences, and hence 
self-priming at either end of the duplex (Koczot et al., 1973; Hauswirth and Berns, 
1977). 
The AAV genome contains two open reading frames (ORFs) designated rep and 
cap which code for non-structural and structural proteins, respectively. Gene 
product diversity is achieved at both ORFs via alternative splicing of messenger 
RNAs (mRNAs) and the use of alternative promoters (Fig. 12). Hence, the rep 
ORF generates four different Rep proteins (designated Rep78, Rep68, Rep52, and 
Rep40) implicated in replication, genome packaging, and establishing latency, 
while the cap ORF facilitates expression of capsid proteins VP1, VP2, and VP3 
which autonomously assemble into icosahedral virions (Daya and Berns, 2008). In 
the absence of a polymerase coding sequence, AAV is entirely dependent on host 
cell mechanisms for replication. 
 
 
Figure 12. AAV genome structure. The wildtype AAV genome contains two ORFs, rep and cap, 
which generate non-structural and structural proteins, respectively. This is facilitated by the use of 
both alternative promoters (P5, P19, P40) and alternative splicing. 
 
As of 2008, twelve different AAV serotypes (AAV1 - AAV12) were described 
and demonstrated to infect human cells and tissues (Daya and Berns, 2008), and 
efforts to characterize each of them in terms of tissue tropism and transduction 
efficiency in vivo are ongoing. The present literature indicates differential general 
susceptibilities to AAV infection between organs, and maximal transduction 
efficiency for each type of tissue seems to depend on the viral serotype. For 
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example, hepatic tissue seems to be readily transduced by a variety of AAV 
serotypes, most efficiently by AAV8 and AAV9, while renal tissue appears 
relatively inert to AAV infection although AAV was originally discovered in 
kidney cells (reviewed in Schultz and Chamberlain, 2008). 
Of these serotypes, AAV2 is by far the best-studied. Extracellular docking of 
AAV2 to host cells is primarily facilitated by binding to heparan sulphate 
proteoglycans (Summerford and Samulski, 1998), while αvβ5 integrin and 
receptors for fibroblast growth factor, among others, act as co-receptors that help 
facilitate clathrin-dependent endocytosis of AAV2 virions (Summerford et al., 
1999; Qing et al., 1999; Duan et al., 1999). The use of ubiquitous heparan 
sulphate proteoglycans as primary receptors explains the broad tropism of AAV2 
which can infect a wide variety of cell types including quiescent, non-dividing 
cells. A schematic representation illustrating the initial steps of AAV transduction 
is depicted in Figure 13 which highlights that the route to the nucleus includes 
endosomal escape of intact viral particles. However, details of nuclear 
translocation thereafter remain to be determined (Daya and Berns, 2008).  
 
 
Figure 13. Intracellular trafficking of AAV. After extracellular docking to the plasma 
membrane, AAV is internalised by clathrin-dependent endocytosis. Nuclear translocation occurs 
on alternative routes, the most prominent involving endosomal escape following induction of 
capsid-associated phospholipase activity during endosomal processing. Uncoating of virions and 
concomitant viral genome release takes place in the nucleus. Viral genomes may remain as stable 
concatemeric episomes or integrate into the host genome (detailed in the main text). Proteasomal 
degradation counteracts successful AAV transduction. From (Schultz and Chamberlain, 2008) 
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1.3.2 Adeno-associated virus as a somatic gene transfer vector  
The general interest to employ viruses as gene therapy vectors is based on the 
inherent possibility to provide therapeutic cargo in a temporally controlled and 
tissue-specific manner. Moreover, successful viral transgene delivery to a 
diseased organ would ideally lead to stable long-term expression of the 
therapeutic gene product, and hence cure the existing problem without a need for 
recurrent therapeutic intervention. Obviously, monogenetic diseases with 
hypomorphic or defective gene expression appear particularly interesting targets 
for such gene therapy approaches, and clinical examples include hemophilia, 
Canavan disease, cystic fibrosis, and muscular dystrophies. 
Many aspects of basic AAV virology detailed in the previous section render this 
virus an especially promising candidate for gene therapy purposes, and 
consequently great interest to exploit AAV arose in the field (e.g. Carter, 2004; 
Daya and Berns, 2008). These promising aspects include AAV’s excellent safety 
profile related to its inherent non-pathogenicity and replication deficiency, as well 
as its property to elicit only weak immune responses which sets it apart from other 
viral vector systems like adenoviruses. AAV’s ability to transduce a wide variety 
of cell types moreover allows its application in a broad range of tissues including 
those harbouring post-mitotic cells which are notoriously difficult to transduce by 
other methods. At the same time, the option to choose between several serotypes 
with different transduction spectra allows for the specific tailoring of an AAV 
gene transfer vector with respect to the target tissue in question. This latter option 
has received even further refinement in recent years by the finding that AAV 
tropism and transduction efficiency can be manipulated by at least two different 
methods, i.e. transcapsidation and the generation of chimeric vectors. 
Transcapsidation designates the process of packaging rAAV genomes flanked by 
ITRs of a given serotype into virion shells built from capsid proteins from another 
serotype (Rabinowitz et al., 2002). This approach helps altering AAV 
transduction profiles as both the ITRs and the capsid composition contribute 
critically to overall transduction efficiency (Choi et al., 2005). Chimeric vectors, 
on the other hand, are virions with capsid protein compositions derived from 
different serotypes. This approach is likewise able to alter both tissue tropism and 
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transduction efficiency compared to parental serotypes (Hauck et al., 2003). 
However, limitations exist with regard to the compatibility of capsid proteins of 
different serotypes to form functional virions (Rabinowitz et al., 2004). Amongst 
this background of major advantages, the only downside of AAV as a gene 
therapy vector is its limited packaging capacity which is restricted to the size of 
the wildtype AAV genome, thus precluding efficient delivery of therapeutic DNA 
exceeding 4.7 kb in length (Dong et al., 1996). 
In contrast to retroviral transduction systems which integrate somewhat randomly 
into the host genome, and thus exhibit significant mutagenic potential, the 
propensity of wildtype AAV to integrate at a specific location (AAVS1) into the 
host genome attracted further attention. As chromosomal integration at AAVS1 
does not occur with absolute reliability, however, it is thus regarded as a double-
edged sword in the clinical setting (Dutheil et al., 2004). Nevertheless, this 
problem is virtually abolished in recombinant AAV (rAAV) vectors which retain 
only some 300 bp of non-transcribed ITR sequences from the wildtype AAV 
genome that are the only cis-acting signals required for genome replication and 
packaging. In addition, replacement of wildtype genomic sequences further 
reduces the probability of an immune response as no viral genes are expressed by 
infected cells. In the absence of wildtype AAV gene products, particularly Rep 
proteins, integration can not occur, and the AAV genomes remain in an episomal 
form, more precisely as head-to-tail, and less frequently as head-to-head or 
tail-to-tail concatemers (Nakai et al., 2000; Schultz and Chamberlain, 2008). 
Importantly, these episomal vector genomes are stable and contribute to long-term 
transgene expression (Nakai et al., 2001). 
In central nervous system (CNS) research, AAV has proven a particularly 
valuable tool due to its dual properties to exclusively infect post-mitotic neurons 
with little if any transduction of glial or other cell types, and to facilitate stable, 
long-term (≥ 2 years) neuronal transgene expression in both rodents and monkey 
(Davidson et al., 2000; Gao et al., 2002). The first evidence for an AAV-mediated 
functional improvement of disease conditions came from a study in which the 
authors ectopically expressed tyrosine hydroxylase in striatal neurons in a rat 
model of Parkinson’s disease (Kaplitt et al., 1994). Thereafter, successful 
improvement of disease symptoms was reported in a large number of studies 
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using AAV-mediated in vivo somatic gene transfer to CNS neurons in animal 
models of various diseases including but not restricted to Parkinson’s, Canavan, 
Alzheimer’s, and Huntington’s disease, epilepsy, and amyotrophic lateral 
sclerosis (reviewed in McCown, 2011; Henriques et al., 2011). 
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1.4 Aim of this Work 
 
Granulocyte/macrophage colony stimulating factor (GM-CSF) has been originally 
identified as a hematopoietic growth factor but has recently been assigned 
important neurotrophic functions in the central nervous system under various 
disease conditions. In addition, pro-neurogenic effects on adult neural stem cells 
were established in vitro. These findings place GM-CSF along with the other two 
major hematopoietic proteins granulocyte colony stimulating factor (G-CSF) and 
erythropoietin (EPO) in a novel group of neuronally active growth factors. 
Because of the abundant expression of the GM-CSF receptor on neurons in 
regions associated with learning and memory such as the cortex and hippocampus, 
we asked whether GM-CSF signalling might be involved in aspects of cognitive 
processing. To address this question, we systematically tested learning and 
memory formation in GM-CSF deficient (GMko) mice by employing a battery of 
behavioural paradigms that assessed both cognitive and sensomotoric aspects of 
rodent behaviour. In a complementary approach, we altered expression levels of 
the ligand-specific GM-CSFRα subunit exclusively in the hippocampus of adult 
wildtype mice using adeno-associated virus vectors for GM-CSFRα 
overexpression and knock-down, respectively, and examined spatial memory 
formation in these animals in the Morris water maze. The induction of long-term 
potentiation in the CA1 hippocampal subfield of GMko mice was examined by 
electrophysiological recordings. Moreover, morphological studies on dentate 
gyrus and CA1 neurons were performed to determine the impact of GM-CSF 
deficiency on neuronal complexity, dendritic spine number, and spine maturation. 
In an independent effort, the generation of a conditional knock-out mouse line for 
the GM-CSF receptor alpha subunit was pursued to obtain a novel and valuable 
tool for future projects. 
  
 
 
 
2 RESULTS 
 
This study was focused on the elucidation of a putative role for GM-CSF in 
learning and memory. For this purpose, among other things, an extensive 
behavioural test battery was applied to GM-CSF-deficient (GMko) mice which 
included a variety of specific learning and memory tasks. These tests were 
preceded by an assessment of more basal aspects of behaviour to complement data 
from subsequent cognitive tests and allow for their proper interpretation. 
 
 
2.1 Effects of GM-CSF deficiency on basal behaviour 
 
2.1.1 Locomotor behaviour in the open field 
The open field test primarily assesses spontaneous locomotor activity in a novel, 
slightly aversive environment which consisted in our case of a white cubicle box 
without a lid. In this exposed arena, animal behaviour is influenced by both 
anxiety and exploratory drive, and these parameters contribute to the amount of 
time spent in the corner or center areas of the arena and to the overall distance 
travelled within the testing period. To facilitate quantification, the open field was 
subdivided into 26 subregions (Fig. 14a), and mice were video-tracked while 
freely exploring the arena individually for 30 min. GMko mice showed reduced 
levels of locomotor activity throughout the 30 min testing period (Fig. 14b,c). 
This effect was not caused by elevated levels of anxiety as animals from both 
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groups spent similar amounts of time in the corner and center regions of the arena 
(Fig. 14d). 
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Figure 14. Open Field test. (A) The floor of the open field arena was subdivided in silico into 25 
squares and a circular center region. (B) Spontaneous locomotor activity in the open field was 
reduced in GMko mice which travelled shorter overall distances over the course of a 30 min 
testing period (p<0.001). (C) Activity was consistently lower in GMko mice (genotype, p<0.001) 
and no initial anxiety-related immobility or altered habituation rate (genotype*time, p>0.05) was 
noted. (D) Times spent in the corner or center regions of the arena were similar between groups 
(both p>0.05). wt, n=18; ko, n=16 animals 
 
 
2.1.2 Analysis of long-term activity 
To confirm reduced spontaneous activity with a different assay, GMko and 
wildtype animals were next tested in a LABORAS cage, an automated device for 
the detection of rodent behaviour based on the analysis of force and vibration 
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patterns. Due to automated analysis, this paradigm facilitated long term 
observation of animals for 12 hours during their nocturnal activity phase, thus 
diminishing any potential experimenter related influences. Again, GMko mice 
travelled a shorter overall distance (Fig. 15a). They also spent less time with 
horizontal locomotion and cage climbing, but spent more time in an immobile 
state (Fig. 15 b-d), thus confirming the reduced spontaneous locomotor activity 
observed in the open field. 
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Figure 15. Spontaneous activity in a LABORAS cage. Spontaneous activity was reduced in 
GMko mice over a 12 hour nocturnal period in which GMko mice spent less time with locomotion 
(A) and cage climbing (B), covered a shorter overall distance (C), and spent more time in an 
immobile state (D). (***, p<0.001); wt, n=18; ko, n=16 animals 
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2.1.3 Assessment of motor function 
To determine whether physical impairments of the motor system contributed to 
the reduced spontaneous locomotor activity of GMko mice, we next tested motor 
function under conditions of forced exercise on a rotating beam. To this end, mice 
were examined on a rotarod under a challenging acceleration protocol. 
Interestingly, this experiment indicated a positive rather than a negative influence 
of GM-CSF deficiency on both motor endurance and coordination as total fall-off 
latencies were increased in GMko mice, an effect that was due to superior 
performance during the first 5 days of testing (Fig. 16). 
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Figure 16. Motor performance on a Rotarod. (A) Animals were tested on a rotarod under a 
challenging acceleration protocol of 4-80 rpm over 300 seconds. (B) GMko mice did not show any 
impairments of the motor system. Instead, motor performance was superior in the early stages of 
training (genotype, p<0.05). wt, n=18; ko, n=16 animals 
 
 
2.1.4 Analysis of anxiety-related behaviour and exploration  
To fully exclude heightened anxiety levels as a reason for diminished locomotor 
activity, we employed the dark-light box paradigm, which offers a choice between 
occupation of a dark and protective environment on the one hand, and a brightly 
illuminated and exposed environment on the other (Fig. 17a). It thus utilizes the 
conflict situation arising from the tendency to explore novel environments and an 
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opposing innate avoidance of exposed areas, the latter increasing with elevated 
levels of inherent anxiety. 
This analysis confirmed anxiety levels to be comparable between GMko and 
wildtype mice which spent similar times in the exposed lit compartment 
(Fig. 17b). Diminished rearing behaviour in the lit compartment of the dark-light 
box was noted as well, indicating reduced levels of exploratory activity (Fig. 17c). 
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Figure 17. Dark-Light Box analysis. (A) The Dark-Light Box is split in two compartments, one 
protected from light, the other exposed and aversively brightly illuminated. (B) Both groups of 
animals spent similar amounts of time in the lit compartment (p>0.05). (C) Rearing behaviour, an 
index of exploratory activity, was greatly diminished in GMko animals (p<0.001). 
wt, n=18; ko, n=16 animals 
 
 
2.1.5 Summary of basal aspects of behaviour 
A strong reduction in spontaneous locomotor activity was noted in two different 
paradigms, i.e. the open field and an automated LABORAS detection system. 
This effect was neither paralleled by altered habituation characteristics nor by 
altered levels of inherent anxiety as judged by open field and dark-light box 
analysis. Physical motor deficits were also ruled out with a rotarod where 
knock-outs performed better rather than inferior compared to wildtype controls. 
This renders reduced exploratory drive as a likely explanation for the observed 
spontaneous hypoactivity, a notion confirmed by the reduced rearing activity of 
GMko mice in the lit compartment of a dark-light box.  
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2.2 Effects of GM-CSF Deficiency on Cognition 
 
2.2.1 Active place avoidance and pain threshold levels 
To examine hippocampus-dependent spatial learning and memory, we initially 
tested animals in an active place avoidance paradigm that has been described 
previously (Serrano et al., 2008). Briefly, animals were placed on a circular, 
rotating metal disk and learned to avoid one non-rotating 60° sector, entry to 
which was punished by mild foot shocks (Fig. 18a). Acquisition occurred rapidly 
within 8 training trials on a single day and both groups learned to avoid the shock 
sector as evidenced by increasing latencies to initial entry (Fig. 18b). However, 
task acquisition was inferior and reached an early plateau in GMko mice. 
Exemplary trajectories from the first and last training trials are shown for 
individual animals from both groups, illustrating inferior performance of 
knock-outs (Fig. 18c). When memory retention was assessed 24 hours after the 
last training trial, the inferior acquisition of GMko mice corresponded to a worse 
recall performance of these animals (Fig. 18d). Importantly, these observations 
were not due to altered plantar pain threshold levels as assessed by the paw 
withdrawal response following application of thermal stimulation (Fig. 18e,f) 
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Figure 18. Spatial learning and memory by active place avoidance and plantar pain 
threshold levels. (A) Schematic illustration of rotating testing disk with pre-defined shock sector. 
(B) Spatial learning was impaired in GMko animals (genotype, p<0.05; genotype*trial, p=0.010). 
(C) Representative trajectories illustrating reduced spatial learning in knock-outs. (D) GM-CSF 
deficiency led to inferior performance levels when spatial memory was assessed 24 hours after 
training (p<0.05). (E) Picture of plantar test apparatus. Thermal stimulation to paws is 
administered with an infrared light emitter via the plastic floor. (Picture provided courtesy of Ugo 
Basile Srl) (F) Paw withdrawal latencies to thermal stimulation were identical between groups 
(p>0.05). wt, n=22; ko, n=21 animals 
 
 
2.2.2 Morris water maze 
In the Morris Water Maze (MWM) animals are required to learn the location of a 
hidden escape platform in a swimming pool by using extra-maze visual cues for 
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orientation. This task is widely considered the gold standard in rodent testing of 
hippocampus-dependent spatial learning and memory.  
Gross visual and motivational deficits that might interfere with the animals’ 
ability to mount the escape platform were ruled out in a visual platform version of 
the task. This analysis revealed no between-group differences of escape latency, 
path length, and velocity (Fig. 19). 
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Figure 19. Visible platform version of the Morris water maze. Escape latency (A), total path 
length to platform (B), and average velocity (C) were all similar between groups (all p>0.05). 
wt, n=22; ko, n=21 animals 
 
Over the course of 12 training days (D1-D12), both groups learned the location of 
the platform as monitored by decreasing escape latencies and path lengths 
(Fig. 20a,b). While a considerable offset difference was noted between groups in 
both acquisition curves, the slopes of these curves were similar, indicating some 
general performance deficit in GMko mice but no specific learning impairment. 
To better understand the underlying behavioural differences between groups, a 
frequency density map was generated by accumulative overlay of swim path 
trajectories. This analysis revealed that knock-outs were more likely to be found 
near pool entry sites during early training sessions and needed longer to develop a 
search pattern in closer vicinity to the platform (Fig. 20c). This suggested that 
increased stress susceptibility interfered with efficient development of 
goal-directed search strategies in knock-outs. In line with this, GMko mice 
displayed other erratic behaviours like high initial velocity (Fig. 20d) and frequent 
platform jump-offs (Fig. 20e) during early training. However, we did not observe 
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any floating behaviour. Due to the differential velocity profiles between groups, 
further analyses were based on escape path length as a swim speed-independent 
parameter.  
The probe trial at D13 revealed a significant difference in the time spent in the 
target area defined as a circle (radius r = 20 cm) around the former platform center 
(Fig. 20f). Covariate analysis using genotype, path length at D12, and their 
interaction as factors revealed an influence of genotype on recall performance 
(p<0.05) that was independent of D12 path length. Therefore, GM-CSF deficiency 
resulted in impaired spatial memory recall 24 h after acquisition. Representative 
probe trial trajectories and cumulative density heat maps for both groups are 
shown as well (Fig. 20g,h). 
To investigate potential differences in platform search strategies during the probe 
trial, we next analysed occupancy of the target area in bins of 10 seconds. Apart 
from an overall offset difference (genotype p<0.01), the slopes of the curves were 
significantly different (p<0.05), suggesting that strategies differed between 
groups. In contrast to controls, knock-outs failed to perform an initially focused 
search in the target area and did not reduce their visiting time markedly upon 
failure to find a platform (Fig. 20i). Importantly, however, the latter was not due 
to a ground effect as both groups occupied the target area well above chance 
levels throughout the 120 s probe trial. 
As this indicated a diminished flexibility of GMko mice to adapting to task 
variations, we consequently explored reversal learning where pre-trained animals 
were subjected to a 5-day (RD1-RD5) protocol with the platform position 
changed from the NW to the SE quadrant. Indeed, reversal learning was clearly 
impaired in GMko mice (p<0.05) in this scenario (Fig. 20j). Collectively, these 
results show that GM-CSF deficiency causes profound spatial memory 
impairments and affects the animals’ behavioural flexibility to respond to altered 
environmental conditions. 
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Figure 20. Effects of GM-CSF deficiency on spatial learning and memory in the Morris 
water maze. (A,B) Escape latencies and swim path lengths were increased in GMko mice at all 
times compared to controls  with a main effect of genotype (p<0.001). However, learning progress 
was comparable between groups as reflected by similar relative decreases in escape latency and 
trajectory lengths, respectively (genotype*day, p>0.05). (C) Frequency density analysis of 
accumulated trajectories reveals thigmotactic behaviour of knock-outs during early training with 
an initial focus on pool entry sites. Platform-focused trajectories develop later and to a lesser 
extent compared to wildtypes. (D) Velocity profiles during training differed between groups 
(genotype, p<0.01, genotype*day, p<0.001). In contrast to controls, knock-outs displayed signs of 
an elevated stress response with initial hyper- and subsequent hypoactivity. (E) Knock-outs also 
displayed pronounced platform jump-off behaviour (genotype, p<0.001). This only subsided 
towards the end of the acquisition period. (F) Spatial memory was impaired in GMko mice which 
spent significantly less time in the target area during the probe trial (p<0.05). While performance 
at D12 clearly affected this parameter (p<0.01), genotype had an independent effect (p<0.05). (G) 
Representative probe trial trajectories illustrating reduced memory accuracy in GMko mice. (H) 
Frequency density maps illustrating inferior memory performance of GMko mice. (I) Occupancy 
of target area during the probe trial in bins of 10 seconds indicates differential platform search 
patterns between groups (genotype, p=0.010; genotype*time, p<0.05). Controls initially perform a 
focused search at the former platform location (FPL) before screening other regions, while, at an 
overall lower rate, knock-outs keep constantly visiting the FPL. (J) Reversal learning was 
impaired in GMko mice (both genotype and genotype*time, p<0.05). Note that path lengths were 
indistinguishable at RD1. wt, n=22; ko, n=21 animals 
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2.2.3 Fear conditioning 
To determine whether other memory systems that are not involved in spatial 
navigation were also affected by GM-CSF deficiency, we tested GMko and 
wildtype mice in a fear conditioning experiment that assesses associative memory 
formation. Both groups showed substantial but indistinguishable freezing 
behaviour in response to repetitive cue-shock pairings during acquisition 
indicating similar associative learning abilities (Fig. 21a). Similarly, fear 
responses to context challenge 24 hours later were comparable between groups 
(Fig. 21a). However, when cue-related fear memory was assessed by challenge 
with the conditioning cue 48 hours after training, fear responses were strongly 
reduced in GMko mice (Fig. 21b). Temporal analysis of freezing behaviour at 
1 s resolution confirmed that the overall difference was due to different levels of 
fear responses to cue presentations (Fig. 21c). 
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Figure 21. Effects of GM-CSF deficiency on fear memory formation. (A) Freezing responses 
were identical during both fear conditioning at day 1 and context challenge at day 2 (both p>0.05). 
(B) Freezing responses to conditioned stimulus 48 hours after training were reduced in GMko 
mice indicating fear memory impairments in these animals. (C) Temporal analysis of freezing 
behaviour at day 3 illustrates that differential fear responses between groups are due to different 
response levels to cue presentations. Bars indicate duration of cue presentation. (***, p<0.001); 
wt, n=22; ko, n=21 animals 
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2.2.4 Summary of cognitive aspects of behaviour 
GM-CSF deficiency was clearly associated with performance deficits in all 
behavioural learning and memory paradigms conducted in this study. Specifically, 
GMko mice showed both spatial learning and spatial memory deficits in the active 
place avoidance (APA) and MWM paradigms, respectively, and reduced fear 
memory formation to cue-shock associations in a fear conditioning (FC) 
experiment. Importantly, altered pain threshold levels were ruled out as a cause 
for reduced performance levels in the APA and FC paradigms which relied on 
aversive foot shock stimulation via the animals’ paws. Moreover, diminished 
behavioural flexibility to adapt to novel environmental configurations was noted 
in knock-outs in both the MWM memory recall trial and a subsequent re-learning 
protocol. Apart from that, these animals displayed a variety of erratic behaviours 
in the MWM, indicating GM-CSF deficiency to additionally cause enhanced 
stress susceptibility. 
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2.3 Effects of GM-CSF Deficiency on Hippocampal 
Morphology 
 
Brains of GMko and wildtype mice were analyzed at both the structural, cellular 
and subcellular level to investigate whether the behavioural deficits associated 
with GM-CSF deficiency were paralleled by morphological defects in the 
hippocampus.  
 
 
2.3.1 Neurite outgrowth 
Primary hippocampal neurons from E18.5 rat embryos were grown in the absence 
or presence of 20 ng/ml GM-CSF to examine a potential any stimulatory effect of 
the neurotrophin on the neurite outgrowth of these cells. Indeed, after 48 hours in 
culture, total neurite length was significantly increased by approximately 13 % in 
the presence of GM-CSF (Fig. 22).  
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Figure 22. GM-CSF stimulated neurite outgrowth in vitro. Application of 20 ng/ml GM-CSF to 
cultures of primary rat hippocampal neurons increased total neurite length per cell by >13 % 
(*, p<0.05). n=100 cells per group 
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2.3.2 Gross hippocampal morphology 
Based on this in vitro result, we next asked whether GM-CSF deficiency was 
associated with morphological deficits in vivo. Measures of hippocampal volume, 
maximal hippocampal width, and distance between dorsal tips of the CA1 and DG 
layers of nuclei revealed no between-group differences, thus ruling out gross 
structural deficits in hippocampal anatomy (Fig. 23a-c). Nevertheless, other 
measures of distances between characteristic points within various planes along 
the rostro-caudal axis indicated minor alterations of unclear relevance in GMko 
hippocampal anatomy including a slight compression of the DG with reduced gap 
width between upper and lower blades of the granule cell layers (Fig. 23d-f). 
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Figure 23. Effects of GMko on gross hippocampal morphology. (A) Hippocampal volume was 
similar between GMko and wildtype mice (p>0.05). (B) Maximal hippocampal width was similar 
between GMko groups (p>0.05). (C) Distance between dorsal tips of CA pyramidal cell and DG 
granule cell layers was similar (p>0.05). (D) Distance between CA1 and CA3 ends of CA 
pyramidal cell layer were increased in medial (p<0.05) but not in rostral, rostromedial, 
mediocaudal, and caudal sections of the hippocampus (all p>0.05). (E) Distance between open 
ends of upper and lower blade granule cell layers were decreased in rostromedial, mediocaudal, 
and caudal sections (all p<0.05). (F) Distance between junction of upper and lower blade granule 
cell layers and the CA1 end of CA pyramidal cell layer were reduced in rostral and rostromedial 
(both p<0.05) and increased in medial sections (p<0.01). Labelling of x-axis in (D)-(F) denotes 
map numbers in (Paxinos and Franklin, 2004). n=6 animals per group 
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2.3.3 Dendritic arborisation 
To investigate the impact of GM-CSF deficiency on hippocampal morphology at 
the cellular level, we next performed full reconstruction of DG neurons from 
GMko and wildtype mice (n=17 and 19, respectively). To this end, hippocampal 
sections stained by the Golgi-Cox method were subjected to image acquisition by 
confocal microscopy, and individual neurons were subsequently reconstructed 
from image stacks using Neuromantic software 
(http://www.reading.ac.uk/neuromantic/). This analysis revealed a shortening by 
33 % in total dendritic length and a decrease by 30% in the number of dendritic 
bifurcations in GMko brains (Fig. 24), thus indicating a reduction of dendritic 
complexity in DG granule cells by approximately one third. 
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Figure 24. Effects of GM-CSF deficiency on dendritic morphology. (A) Representative 
reconstructions of GMko and wildtype DG granule cells showing reduced dendritic complexity of 
GMko neurons. (B,C) Quantification of total dendritic length and dendritic branch points of DG 
granule cells confirming rudimentary arborisation of GMko neurons. (*, p<0.05); 
wt, n=19; ko, n=17 cells 
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2.3.4 Dendritic spine density 
We subsequently examined the density of dendritic spines in GMko and wildtype 
animals to address the question whether GM-CSF deficiency was also associated 
with morphological deficits at the subcellular level. This analysis was performed 
in two different hippocampal subregions, i.e. the DG and CA1 subfield. In GMko 
mice, we found dendritic spine density to be reduced in these areas by 15 % and 
31 %, respectively (Fig. 25), thus demonstrating reduced dendritic complexity at 
the subcellular level. 
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Figure 25. Effects of GM-CSF deficiency on dendritic spine numbers. (A) Representative 
examples of dendrites from GMko and wildtype DG granule cells illustrating reduced spine 
density in knock-outs. (B,C) Spine density quantification of DG granule cells (str. moleculare) and 
CA1 pyramidal neurons (str. radiatum) showing reduced dendritic spine densities in both regions 
of the GMko brain. (***, p<0.001); wt, n=49; ko, n=54 cells from 3 animals each. 
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2.3.5 Dendritic spine morphology 
Dendritic spines are frequently classified into three morphological categories, i.e. 
thin filopodial, stubby, and mushroom-shaped spines. Although controversy exists 
about the functional characteristics of these different spine types, mushroom 
spines have been frequently associated with high synaptic strength and efficient 
synaptic transmission. We thus examined whether the relative abundance of this 
spine type in the DG and CA1 subfields would differ between genotypes. In fact, 
GMko mice displayed a smaller percentage of mushroom-like dendritic spines in 
both hippocampal subfields with a reduction of 32 % in the DG, and 37 % in the 
CA1 region (Fig. 26). 
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Figure 26. Effects of GM-CSF deficiency on the numbers of mushroom-shaped dendritic 
spines. (A) Representative example of a dendritic spine with mushroom-like morphology 
(arrowhead). (B,C) Percentage of mushroom-shaped dendritic spines was reduced in both dentate 
gyrus and CA1. (**, p<0.01; ***, p<0.001); wt, n=49; ko, n=54 cells from 3 animals each. 
 
Collectively, these results consistently show a reduction in dendritic complexity at 
various cellular and subcellular levels and suggest that excitatory synaptic input is 
reduced by approximately one third in the GM-CSF deficient hippocampus. 
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2.4 Effects of GM-CSF Deficiency on Hippocampal 
Electrophysiology 
 
In light of the behavioural deficits of GMko mice and their morphological 
aberrations in the hippocampus, we next asked whether GM-CSF deficiency 
might have an effect on hippocampal long-term potentiation (LTP). We thus 
investigated whether LTP between CA3 Schaffer collaterals and the CA1 
dendritic region might be altered in the absence of GM-CSF (wt, n=21 slices; 
GMko, n=23 slices; n=8 mice each). These measurements were performed in 
collaboration with the group of Prof. Draguhn at the Institute of Physiology and 
Pathophysiology by Dr. Martin Both and Simon A. Kranig. 
 
 
2.4.1 Induction and persistence of long-term potentiation 
Prior to induction of LTP, maximal population spike amplitudes and spontaneous 
activity were monitored as described previously (Weiss et al., 2008) to rule out 
genotype-related differences in baseline properties of important 
electrophysiological parameters such as electrical excitability and endogenous 
firing rate. This analysis revealed no between-group differences (Fig. 27a-e). 
Long-term potentiation at Schaffer collaterals was then successfully induced in 
both groups using a delta burst protocol adjusted to evoke population spikes with 
50 % of the maximal amplitude, and was monitored for 60 min following 
induction. However, no impairment of LTP induction or maintenance was noted 
in GMko animals as judged by both slope and population spike analysis 
(Fig. 27f). 
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Figure 27. Effects of GM-CSF deficiency on baseline electrophysiological parameters and 
long-term potentiation. (A) Maximal population spike amplitudes were similar between groups 
(p>0.05). (B,C) Both sharp wave amplitudes and frequencies were identical between groups (both 
p>0.05). (D,E) Both ripple energy and ripple frequency were identical between genotypes (both 
p>0.05). (F) LTP between CA3 Schaffer collaterals and the CA1 dendritic region was induced 
using a delta burst protocol at timepoint 0 min, and monitored for 60 min after induction. Shown 
are population spike amplitudes as means ± s.e.m. GMko mice do not show impaired LTP 
induction when comparing the last 10 min of the protocol. Insets depict individual traces of wt and 
ko animals prior and after LTP induction. (wt, n=21 slices; GMko, n=23 slices; n=8 mice each) 
 
 
2.4.2 Paired-pulse analysis 
To test for potential genotype-related alterations in short-term plasticity and in the 
probability of presynaptic transmitter release, paired-pulse facilitation was 
assessed in GMko and wildtype mice. Again, no between-group differences were 
observed when responses to paired-pulse stimulation at 20 ms delay were 
examined both before and after induction of LTP (Fig. 28). As expected, 
paired-pulse stimulation did not lead to further enhancement of response 
intensities following LTP induction. 
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Figure 28. Effects of GM-CSF deficiency on paired-pulse facilitation. (A) Paired-pulse 
facilitation was similar between groups both prior to and following LTP induction (both p>0.05). 
As expected, no further response increase was obtained by paired-pulse stimulation after LTP 
induction. (B) Paired-pulse facilitation decreased by approximately 20 % after LTP induction. This 
effect was similar in both groups (p>0.05). (wt, n=21 slices; GMko, n=23 slices; n=8 mice each) 
 
From these data we conclude that no major electrophysiological distortions are 
obvious in GM-CSF deficient animals, despite the morphological deficits 
observed in GMko mice. 
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2.5 Acute Manipulation of Adult Hippocampal 
GM-CSF Signalling 
 
Constitutive deficiency for GM-CSF in the GMko mouse line may impact on 
neuronal development, and thus cause secondary effects on behaviour and 
cognition. To confirm our hypothesis that the observed cognitive deficits in 
GM-CSF knock-out mice were, at least partially, due to an acute lack of GM-CSF 
signalling in the adult brain, we chose a second, independent approach of 
AAV-mediated somatic gene transfer to complement the knock-out study in 
several ways by 1) use of wildtype animals that developed normally until 
adulthood; 2) strictly hippocampus-specific targeting by stereotaxic viral vector 
delivery; 3) exclusively neuron-specific modulation of GM-CSF signalling due to 
strict neurotropism of AAV in the CNS; 4) modulation of ligand-specific 
GM-CSF receptor alpha levels instead of GM-CSF ligand. 
 
 
2.5.1 Adeno-associated virus vector constructs and functional 
characterisation 
Vectors were designed to overexpress (AAV-GMCSFRα) or knock-down 
(AAV-shRNA) hippocampal GM-CSFRα levels in adult mice, while a third group 
of animals received vector AAV-UNC carrying a universal negative control 
construct (Fig. 29). 
 
RESULTS 58 
GMRαCBA IRES eGFP
U6 hrGFPCBAshRNA
U6 hrGFPCBAUNC
GM-CSFRα overexpression
GM-CSFRα knock-down
control
 
Figure 29. AAV constructs employed in this study. Vectors were designed to modulate 
GM-CSFRα levels in a bidirectional manner. CBA, chicken beta actin promoter; GMRα, GM-CSF 
receptor alpha subunit; IRES, internal ribosome entry site; eGFP, enhanced green fluorescent 
protein; U6, human U6 promoter; shRNA, small hairpin RNA; hrGFP, humanized renilla green 
fluorescen protein; UNC, universal negative control 
 
Initially, a screen was conducted with four candidate AAV-shRNA constructs 
(sh427, sh845, sh1274, sh1542) to identify one that robustly knocked-down 
GM-CSFRα levels. We first tried to estimate knock-down efficiency at the mRNA 
level in the murine neural cell line NSC34 (Cashman et al., 1992). Attempts to 
quantify knock-down of endogenous transcript levels failed repetitively due to the 
low abundance of GM-CSFRα mRNA. We thus measured knock-down efficiency 
of our candidates on a background of artificially enhanced GM-CSFRα transcript 
levels by co-transfecting the shRNA constructs with plasmid AAV-GMCSFRα 
into NSC34 cells. Quantitative real-time PCR on cDNA from these cells indicated 
a 40 % - 50 % knock-down by constructs sh427, sh845, and sh1542, while sh1274 
showed an unusually high variance in replicate experiments and was therefore no 
longer considered. Importantly, co-transfection of the negative control construct 
AAV-UNC with pAAV-GMCSFRα did not reduce GM-CSFRα transcript levels 
(Fig. 30). 
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Figure 30. In vitro GM-CSFRα knock-down screening at mRNA level. Three of four shRNA 
candidates knocked-down artificially enhanced GM-CSFRα levels in NSC34 cells following 
co-transfection with plasmid AAV-GMCSFRα. (n=2) 
 
Subsequently, candidate shRNA function was assessed on the protein level by 
immunocytochemical analysis of HEK293 cells co-transfected with plasmids 
pAAV-GMCSFRα-3xFlag and the individual candidate shRNA constructs. 
Transfected HEK293 cells were stained for the Flag tag to indirectly detect 
murine GM-CSFRα using Cy3-labelled secondary antibodies. Cy3 fluorescence 
signal intensity was then correlated at the single cell level to shRNA 
construct-derived GFP intensity. This analysis confirmed reliable 
shRNA-mediated reduction of Flag-tagged GM-CSFRα protein levels by 
40 % - 80 % for all four candidates (Fig. 31). 
Based on these results we focused on sh427 and sh1542 for assessment of 
knock-down function on endogenous hippocampal GM-CSFRα protein levels 
in vivo. Western blot analysis on hippocampal protein samples prepared from 
adult wildtype mice three weeks following unilateral hippocampal injection of 
AAV constructs expressing the respective candidate shRNAs revealed slightly 
better knock-down effects for sh427 (Fig. 32). We thus employed construct 
AAV-sh427 in this study. 
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Figure 31. In vitro GM-CSFRα knock-down screening at protein level. HEK293 cells were 
co-transfected with plasmids AAV-GMCSFRα-3xFlag and individual shRNA candidate 
constructs. (A) All shRNA constructs reduced the Flag/GFP ratio in co-transfected HEK293 cells 
indicating knock-down of 3xFlag-tagged GM-CSFRα protein levels (ANOVA, p<0.001; Tukey-
Kramer HSD, p<0.001 for UNC versus any other group). (B) Reductions in Flag/GFP ratios in (A) 
were not due to higher levels of GFP expression in UNC. In fact, GFP levels were similar in all 
groups except for sh845 which led to slightly lower GFP expression levels (ANOVA, p<0.05; 
Tukey-Kramer HSD, p<0.05 for UNC versus sh845). (C) Likewise, reductions of Flag/GFP ratios 
in (A) were not due to increased expression of Flag-tagged GM-CSFRα in response to 
co-transfection with UNC plasmid (p>0.05). n>100 cells per group 
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Figure 32. In vivo GM-CSFRα knock-down screening at endogenous protein level. Western 
blots on hippocampal protein samples of unilaterally injected mice 3 weeks after surgery revealed 
successful up- and down-regulation of endogenous GM-CSFRα protein levels by 
AAV-GMCSFRα and both AAV-shRNA constructs, respectively. Knock-down was more efficient 
with AAV-sh427 compared to AAV-sh1542. (ipsi, ipsilateral side; contra, contralateral side) 
 
All viral constructs, AAV-GMCSFRα, AAV-sh427, and AAV-UNC, led to robust 
hippocampal transduction based on reporter gene expression as exemplified for 
AAV-UNC in (Fig 32a), and hippocampal GM-CSFRα protein levels differed in 
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the expected construct-dependent manner after bilateral stereotaxic injection (Fig 
32b). Quantification of Western blots revealed GM-CSFRα levels to be 
knocked-down by approximately 42 % and increased by approximately 1000 % 
following injection of AAV-sh427 and AAV-GMCSFRα, respectively, as 
compared to AAV-UNC. 
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Figure 33. AAV-mediated transgene delivery to the adult murine hippocampus for 
bidirectional manipulation of GM-CSFRα levels in wildtypes. (A) Representative example of 
robust hippocampal reporter gene expression (AAV-UNC; CA1 region). Reference bar, 50 µm (B) 
GM-CSFRα levels in western blots of AAV-treated hippocampal samples differ in the expected 
construct-dependent manner. (C) Quantification of blot in (B). (**, p<0.01) 
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2.5.2 Effects of viral constructs on baseline activity 
Animals were bilaterally infused intrahippocampally with viral vector solutions 
by a stereotaxic approach. Three weeks following surgery, when AAV-mediated 
transgene expression reached stable peak levels, all animals were examined in an 
open field experiment to assess aspects of baseline behaviour. No between-group 
differences were found in total distance travelled, and time spent in the corner or 
center regions of the arena (Fig 33). Thus, baseline activity and anxiety-related 
behaviour was similar irrespective of AAV treatment. 
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Figure 34. Effects of hippocampus-specific AAV treatment on basal behaviour in an open 
field. (A) Locomotor activity was not different between groups which travelled similar distances 
over the course of a 30 min examination (p>0.05). (B,C) Anxiety-related behaviour was not 
different between groups as judged by similar amounts of time spent in the center (B) and corner 
(C) regions of the arena (both p>0.05). n=19 animals per group 
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2.5.3 Effects of viral constructs on spatial learning and memory 
When tested in the MWM, all three groups performed similarly during task 
acquisition over 11 training days indicating comparable spatial learning abilities 
(Fig 34a,b). However, memory recall in the probe trial was dependent on viral 
constructs as time spent in the target area was increased or reduced in AAV-
GMCSFRα and AAV-sh427, respectively (Fig 34c, ANOVA, p=0.05; Tukey-
Kramer HSD, p<0.05 for AAV-GMCSFRα vs. AAV-sh427).  
These findings corroborate the results obtained with the GMko animals and 
demonstrate that adult hippocampal GM-CSF signalling affects learning and 
memory independent of potential developmental effects of GM-CSF deficiency. 
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Figure 35. Impact of AAV-mediated manipulation of hippocampal GM-CSFRα levels on 
spatial learning and memory in the MWM. (A) Learning curves were indistinguishable between 
groups (genotype*day p>0.05). (B) Area under the curve plot of spatial learning in the MWM 
(genotype p>0.05). (C) Memory accuracy of the former platform location during the probe trial 
was dependent on hippocampal GM-CSFRα levels with an impairment and improvement caused 
by treatment with AAV-sh427 and AAV-GMCSFRα, respectively, as judged by the time spent in 
the target area. (*, p<0.05); n=19 animals per group 
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2.6 Generation of GM-CSF Receptor alpha 
Conditional Knock-Out Mice 
 
 
The conditional ablation of genes in a tissue-specific manner has become a 
powerful tool in neuroscience research as it provides an option to study targeted 
genetic loss-of-function in adult animals without effects on prior developmental 
stages. The generation of a GM-CSFRα conditional knock-out (GM-CSFRα-cko) 
mouse line was intended to facilitate future studies on GM-CSF function that are 
not feasible with currently available tools, such as investigating the effects of 
GM-CSF signalling in particular hippocampal subregions. Notably, however, 
other fields of biological research might benefit from GM-CSFRα-cko mice as 
well given the pleiotropic peripheral functions of this cytokine. The engineering 
of this mouse line was expected to be potentially challenging as, to date, the 
European Conditional Mouse Mutagenesis Program (EUCOMM) run by an 
international consortium struggling to generate conditional knock-out mouse lines 
for every protein-coding gene, failed to obtain a gene targeting vector for the 
GM-CSFRα gene (http://www.knockoutmouse.org/). 
 
 
2.6.1 Gene targeting vector design 
Physically located on chromosome 19 of the murine genome, the GM-CSFRα 
gene Csf2ra spans 4 kb of sequence, consists of 12 exons, and generates a spliced 
transcript of approximately 1850 nucleotides. The introns are very small with only 
87-159 nucleotides in length, except for intron #1 which comprises almost 1 kb of 
sequence. Its adjacent exons #1 and #2 are remarkable as the former is entirely 
composed of 5’ untranslated region (5’-UTR), while the latter immediately begins 
with the start codon ATG where translation of the receptor chain is initiated 
(Fig. 36a). Given these structural features, options for placing loxP sites were very 
limited as modifications of small introns pose the risk of interfering with the 
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splicing machinery in the conditional allele. Hence, loxP sites were placed in 
direct orientation in the last third of intron #1 and downstream of the last exon, 
respectively, such that Cre-mediated recombination would excise the full-length 
Csf2ra coding sequence except for the non-coding exon #1 (Fig. 36b). To 
facilitate screening of homologously recombined embryonic stem cells by both 
positive and negative selection, an FRT-flanked neomycin resistance cassette 
(neoR) was included upstream to the second loxP site, and a herpes simplex virus 
thymidine kinase expression cassette downstream to the 3’ homology arm, 
respectively (Fig. 36b). Flanking neoR with FRT sites allows for Flp 
recombinase-mediated cassette removal from targeted ES cells prior to blastocyst 
injection. 
To allow for convenient monitoring of the Cre-mediated conversion to a Csf2ra 
knock-out allele, the vector was further equipped downstream of the second loxP 
site with a promoterless eYFP-coding ORF carrying (i) upstream stop codons in 
all frames to prevent leaky reporter gene expression from cryptic promoters in the 
conditional allele, and (ii) splice acceptor sequences derived from Csf2ra 
intron #1 at its 5’ end (Fig. 36b). In this way, excision of the Csf2ra coding 
sequence would concomitantly bring the previously silent reporter cassette under 
transcriptional control of the endogenous Csf2ra promoter and facilitate splicing 
of Csf2ra exon#1 to eYFP using endogenous Csf2ra exon #2 splice acceptor 
sequences (Fig. 36c).  
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Figure 36. Design of the Csf2ra gene targeting vector and strategy. (A) The full-length Csf2ra 
transcript consists of 12 small exons. (B) The wildtype Csf2ra gene is converted to a targeting 
vector with a short 5’ and a longer 3’ homology arm. The rationale behind the overall design is 
detailed in the main text. Note the location of loxP sites (red triangles) in Csf2ra intron #1 and 
downstream of the Csf2ra coding sequence, respectively. (C) Cre-mediated excision of Csf2ra 
coding sequences causes splicing of the untranslated Csf2ra exon #1 to the eYFP reporter, thus 
skipping the artificial stop codons upstream of the eYFP translation initiation site. Csf2ra 
sequences: open boxes, untranslated regions; filled boxes, translated regions 
 
 
2.6.2 Gene targeting vector characterisation 
The expected vector size of 21.3 kb was confirmed by restriction enzyme digest 
(Fig. 37a). Additionally, all junctions between functional elements of the targeting 
vector were sequence-verified on both strands. Subsequently, feasibility of 
Flp recombinase-mediated excision of the neomycin resistance cassette was 
confirmed by PCR on plasmid DNA preparations from circular 
targeting vector / Flp recombinase co-transfections of the neural cell line NSC34 
(Fig. 37b). Finally, generation of a Csf2ra exon #1-eYFP fusion transcript was 
confirmed by PCR on cDNA from ES cells co-electroporated with 
targeting vector / Cre recombinase. Importantly, formation of fusion transcripts 
occurred in a strictly Cre-dependent manner, as evidenced by PCR specific for the 
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fusion transcript followed by subsequent fragment sequencing, thus ruling out 
spontaneous formation of fusion transcripts by illegitimate splicing (Fig. 37c).  
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Figure 37. Characterisation of Csf2ra targeting vector. (A) Linearization by SbfI digest reveals 
expected vector size of approximately 23.1 kb. (B) PCR with primers flanking the neo cassette on 
plasmid DNA preparations from NSC34 cells obtained 48 hours after transfection. Band sizes: neo 
cassette, 2033 bp; Flp-recombined neo cassette, 449 bp. Note that removal of neo cassette occurs 
only in the presence of Flp recombinase. (C) PCR with primers located within Csf2ra exon #1 and 
eYFP ORF, respectively, on cDNA preparations from murine ES cells obtained 24 hours after 
(co-)transfection. Note that a exon #1-eYFP fusion transcript is only found after co-transfection of 
the targeting vector with Cre recombinase.  
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2.6.3 Targeting and screening in embryonic stem cells 
Following electroporation of the linear targeting vector into ES cells, candidate 
ES cell clones growing under neomycin selection were isolated and analyzed by 
PCR for homologous recombination. Screening involved verification of 
site-specific recombination at both ends of the vector and verification of 
heterozygosity for neoR (Fig. 38). A total of 4 clones positive for all parameters 
were identified. These are ready for future clonal expansion and subsequent 
blastocyst injection. 
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Figure 38. Screening of Csf2ra conditional knock-out ES cells. (A) Illustration of PCR 
screening strategy. Note that wildtype alleles will not generate any bands in both the 5’ and 3’ 
homology arm PCRs as the 3’ end of one primer of each pair lies in vector-specific sequences. 
Note also that, conversely, the PCR involving neoR sequences yields bands of different size for 
wildtype Csf2ra and vector templates. (B) Four clones positive (A7, B2, D1, D4), and two clones 
negative (B3, D3) for 5’ homologous recombination are shown. (C) The same banding pattern 
observed in (B) is found for all six clones when homologous recombination is assessed at the 
longer 3’ homology arm. (D) Clones A7, B2, D1, and D4 show both wildtype (0.5 kb) and 
vector-derived (3.6 kb) bands when neoR / eYFP sequences were analyzed, thus confirming 
heterozygosity for the targeting vector. Instead, clones B3 and D3 only carry wildtype Csf2ra 
alleles. All symbols in (A) as in Fig. 36. 
  
 
 
 
3 DISCUSSION 
 
The data presented here demonstrates that GM-CSF signalling in the murine brain 
plays a hitherto unrecognized important role in processes underlying learning and 
memory. This conclusion is reached by assessing a broad array of cognitive 
functions in GM-CSF knock-out mice, and in mice with targeted manipulations of 
GM-CSF receptor α levels specifically in the adult hippocampus.  
 
3.1 GM-CSF deficiency causes specific memory deficits 
 
The GM-CSF-deficient mouse line displayed broadly impaired learning and 
memory performances in all cognitive paradigms investigated including an active 
place avoidance task, the Morris water maze, and a fear conditioning experiment. 
These deficits were detected amongst a background of other behavioural 
alterations including reduced spontaneous locomotor activity which appeared to 
be caused by a diminished central drive for exploration in the absence of motor 
unit defects. While this activity reduction might potentially perturb the 
interpretation of the learning tasks, close behavioural analysis negates the 
existence of such conflict. 
For example, in the fear conditioning paradigm, low levels of activity could lead 
to an overestimation of freezing behaviour and fear memory retention as the 
absence of motor activity during challenge with a previously shock-associated 
stimulus serves as the behavioural read-out of successful fear memory formation. 
Since we observed reduced rather than enhanced freezing responses in 
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knock-outs, detection of locomotion-related false positive effects appears 
unlikely. Instead, diminished levels of activity might, if any, have rather caused an 
underestimation of the fear memory deficit observed in knock-out mice. 
In the MWM, on the contrary, decreased activity could prolong escape latencies, 
and hence overshadow learning progress which might lead to false positive 
acquisition deficits. If very pronounced, reduced motor activity might even 
prevent goal-directed behaviour in the MWM altogether. While the latter was 
clearly ruled out by the continuous decrease in escape latencies over time in both 
groups, we circumvented the latency problem by using escape path length as a 
swim speed-independent parameter that is gradually reduced during acquisition 
through increasingly direct trajectories. Moreover, absence of both visual and 
motivational deficits to mount the platform during visually cued trials further 
indicates that deficits of GMko mice were correctly ascribed to spatial memory 
impairments. 
In summary, inferior performance of GMko mice in our cognitive behavioural test 
battery appears due to genuine learning and memory deficits. In line with this, the 
presence of aversive stimuli during cognitive testing apparently led to 
disinhibition of voluntary activity in knock-outs as exemplified by the comparable 
activity levels between groups in the active place avoidance paradigm. 
 
3.2 Mechanisms for reduced memory performance 
 
The cognitive deficit of GMko mice was paralleled by marked reductions of 
hippocampal dendritic complexity. We observed decreased hippocampal dendritic 
spine densities and a relative loss of the likely more mature mushroom-shaped 
spines (Matsuzaki et al., 2001) in the CA1 and DG subfields. These alterations 
present a convincing morphological correlate of cognitive impairment given the 
paramount role the hippocampus plays in learning and memory, and the fact that 
neuronal circuit formation is known to critically depend on dendritogenesis since 
the dendritic compartment serves as the primary input site for neuronal 
information processing. As the elaboration of the dendritic tree determines both 
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the amount and distribution of synaptic input sites, it may thus limit the available 
cellular substrate for plasticity events required in learning and memory, and hence 
limit the capacity of pyramidal neurons to partake in complex neuronal networks.  
Moreover, on the background of GMko-associated reductions in dendritic 
complexity, we observed concomitant morphological changes in the population of 
dendritic spines in the DG and the CA1 subfield including both a decrease in 
dendritic spine density and a relative loss of mushroom-shaped spines. Although 
conclusive evidence is still missing, this type of spine has been correlated with 
high synaptic strength by numerous studies (Chakravarthy et al., 2006; Geinisman 
et al., 1991; Matsuzaki et al., 2001). These alterations in the spinogenesis of the 
GMko brain could thus have aggravated the impact of reduced dendritic 
arborisation on hippocampal malfunction both individually or synergistically, as 
they represent a further reduction in the quantity of excitatory synaptic input sites, 
as well as a presumably disadvantageous qualitative change in the composition of 
the dendritic spine population. 
It was shown previously that Akt, Stat3 and Erk pathways are major pathways 
activated by GM-CSF in neurons (Schabitz et al., 2008). Both PI3K/Akt and 
Ras/MAPK pathways have been implicated in dendritic size and complexity 
regulation (Kumar et al., 2005; Jan and Jan, 2010; Jaworski et al., 2005), and 
therefore present likely candidates to mediate the observed effects of GM-CSF in 
dendritic morphology. 
Despite these morphological limitations we did not observe a reduction in long-
term potentiation (LTP). Obviously, the excitatory postsynaptic potential (EPSP) 
generated by fewer synaptic inputs in the markedly pruned dendritic tree of CA1 
pyramidal neurons is relatively larger than the one elicited in wildtype neurons, 
possibly because of the smaller surface area and volume of the dendrites. 
Although overall strength of post-tetanic EPSP is not impaired, it is 
straightforward to assume that the ability to form complex neuronal networks for 
memory retention is strongly affected by the decreased number of possible 
excitatory synaptic input sites. The GMko animals are therefore an interesting 
counterexample for the often claimed straight correlation of LTP and learning and 
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memory performance, and rather underline that the relationship between the two 
phenomena is more complicated (Neves et al., 2008). 
 
3.3 Spatio-temporally regulated alterations of 
GM-CSF signalling affect spatial memory 
  
The relevance of neuronal GM-CSF signalling for cognitive processes was further 
confirmed by a fully independent and complementary in vivo approach in which 
AAV-mediated somatic gene transfer was employed to specifically transduce 
hippocampal neurons of genotypic wildtype mice. Here, in contrast to the knock-
out mice, we targeted a different component of the GM-CSF signalling pathway 
by modulating expression levels of the ligand-specific GM-CSF receptor α 
subunit in a bidirectional manner. This alteration was confined to the 
hippocampus, and occurred only after animals had reached adulthood. The higher 
developmental and spatial confinement of changes in GM-CSF signalling likely 
explains the very specific effects on spatial memory recall. We believe that 
GM-CSF likely acts on both a developmental or chronic and on a more acute 
level, and while all of these components are compromised in the knock-out 
animals, only the more acute effects are perturbed in the AAV-treated mice. 
While the strong morphological alterations in the dendritic structure are likely one 
component of the long-term alteration of the GM-CSF system, it remains to be 
defined what physiological and ultrastructural changes occur in the more acute 
adult manipulation of this system.  
 
3.4 Other hematopoietic cytokines in the brain 
 
GM-CSF is closely related at the functional level to other hematopoietic growth 
factors like erythropoietin (EPO) and granulocyte-colony stimulating factor 
(G-CSF). Recently, neuronal receptor expression for all of these growth factors 
has been demonstrated with particularly high expression levels in cortical and 
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hippocampal neurons (Digicaylioglu et al., 1995; Schneider et al., 2005; Schabitz 
et al., 2008). Subcutaneous injections of G-CSF improved spatial learning in 
wildtype rats (Diederich et al., 2009a) while, conversely, a phenotypic analysis of 
G-CSF knock-out mice revealed disruptions of memory formation along with 
decreased neuronal complexity in the hippocampus (Diederich et al., 2009b). 
Intraperitoneal EPO injections enhanced hippocampus-dependent memory in 
wildtype mice (Adamcio et al., 2008; El-Kordi et al., 2009). This was also 
observed in transgenic mice expressing constitutively active EPO receptors in 
cortical and hippocampal pyramidal neurons (Sargin et al., 2011). Enhanced 
levels of adult hippocampal neurogenesis after peripheral EPO injections have 
been reported as well (Leconte et al., 2011). Clinical studies with EPO suggest 
that these findings may be translatable to patients with cognitive problems 
(Ehrenreich et al., 2007a; Ehrenreich et al., 2007b; Marsh et al., 1991). Our data 
establish that the group of these hematopoietic factors as a whole shares highly 
analogous functions in the CNS, extending from basic anti-apoptotic to high level 
neuronal network functions. In line with this, all three factors have been 
established as neuroprotective agents with beneficial effects in a variety of 
neurodegenerative diseases and cerebrovascular events including stroke (Schabitz 
et al., 2003; Schneider et al., 2005; Wang et al., 2004; Schabitz et al., 2008), 
amyotrophic lateral sclerosis (Henriques et al., 2011; Pitzer et al., 2008; Grunfeld 
et al., 2007; Tanaka et al., 2006) and Parkinson’s disease (Ganser et al., 2010; 
Meuer et al., 2006; Kim et al., 2009). These properties are shared with other 
neurotrophic factors such as BDNF (brain-derived neurotrophic factor) which is 
known as a key determinant for memory formation and synaptic strength in the 
hippocampus (Korte et al., 1996; Korte et al., 1998).  
 
3.5 Therapeutic potential 
 
Collectively, our results suggest that GM-CSF signalling plays a novel role in 
learning and memory. Unlike most other neurotrophic proteins, GM-CSF is able 
to pass the intact blood-brain barrier, and is well-tolerated in humans. Importantly, 
we have shown in the AAV experiment that while a decrease in signalling 
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worsens memory performance, an increase improves it. Although it remains to be 
determined if and at what doses peripherally applied GM-CSF is able to improve 
cognitive deficits, it certainly is a bona fide candidate for cognitive enhancement. 
It is interesting in this regard that peripheral application of GM-CSF counteracted 
scopolamine-induced acute cognitive deficits (Bianchi et al., 1996), and that a 
recent report by Boyd and co-workers indicated that GM-CSF treatment was able 
to reverse cognitive deficits in a mouse model of Alzheimer’s disease (Boyd et al., 
2010). Although the authors ascribed the beneficial effect of GM-CSF treatment 
to the reduction of amyloidosis, it is tempting to assume in the light of our 
findings that direct effects on cognitive processing were involved.
  
 
 
 
4 MATERIALS AND METHODS 
 
4.1 Animals 
 
Animals were housed in groups of 3-5 under standard conditions on a 12-h 
light/dark cycle with lights on at 7:00 AM and water and food available 
ad libitum. The GM-CSF-deficient mouse line was a gift from Jeffrey A. Whitsett 
and has previously been described in many studies (Berclaz et al., 2007; LeVine 
et al., 1999; Yoshida et al., 2001). Wildtype C57Bl/6 mice were obtained from 
Charles River (CRL, Sulzfeld, Germany). All experiments were performed in 
accordance with the European Communities Council Directive 86/609/EEC for 
the care and use of laboratory animals for experiments and were approved by the 
responsible local authorities (Regierungspräsidium Karlsruhe, Germany). 
 
4.2 Design of AAV expression constructs 
 
The vector for overexpression of GM-CSFRα was based on AAV expression 
cassette pAAV-CBA-pl-IRES-EGFP-WPRE-bGHpA (provided by 
Dr. Matthias Klugmann, University of New South Wales, Sydney, Australia) 
containing a CMV immediate early enhancer / chicken β-actin hybrid promoter 
(CBA), a polylinker (pl), an IRES element, the EGFP cDNA, the woodchuck 
hepatitis virus post-transcriptional regulatory element (WPRE), and the bovine 
growth hormone polyadenylation sequence (bGHpA). This cassette was flanked 
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by AAV2 inverted terminal repeats (ITRs). Vector AAV-GMCSFRα was 
constructed by PCR amplification of the murine GM-CSFRα ORF from a murine 
cDNA library using primers GMCSFRα_s (GGG GAC AAG TTT GTA CAA 
AAA AGC AGG CTC TAC CAT GGC AGG AAG CCC CCT GTC TC) and 
GMCSFRα_as (GGG GAC CAC TTT GTA CAA GAA AGC TGG GTC CTA 
GGG CTG CAG GAG GTC CTT C) and subsequent subcloning into the pl site. 
The final construct was sequence verified on both strands. 
Vectors for small hairpin RNA (shRNA) expression were based on the AAV2 
ITR-flanked shRNA expression cassette pAM/U6-pl-CBA-hrGFP-WPRE-bGHpA 
described earlier (Franich et al., 2008). This vector harbours a humanized renilla 
GFP (hrGFP) reporter gene expression cassette under control of a CBA hybrid 
promoter along with a shRNA expression cassette with a RNA polymerase III 
compatible human U6 promoter. For knock-down of GM-CSFRα transcript 
levels, target sequence GGA GGC TGA GCT TCG TCA ACG was identified 
with Invitrogen’s BLOCK-iT™ RNAi Designer web tool, and complementary 
DNA oligonucleotides encoding shRNAs directed against this target sequence 
were generated using Ambion’s pSilencer™ Expression Vectors Insert Design 
Tool. For the loop structure, sequence GTG AAG CCA CAG ATG was used as 
described previously (Zeng and Cullen, 2004). Annealed oligonucleotides were 
BamHI x HIndIII-subcloned into the pl site downstream of the U6 promoter. 
Based on the location of the target sequence in the GM-CSFRα ORF, the 
resulting vector was termed AAV-sh427. The same expression cassette and 
cloning strategy was used for generation of a control vector which drove 
expression of the universal negative control shRNA “UNC” with the validated 
non-targeting sequence ACT ACC GTT GTT ATA GGT G (Yang et al., 2005). 
 
4.3 Production of AAV 
 
Chimeric AAV vectors containing AAV serotype 1 and 2 capsid proteins in a 1:1 
ratio were generated as described earlier (Klugmann et al., 2006). Briefly, 
HEK293 cells were CaPO4-transfected with the respective AAV expression 
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plasmid, the adenoviral helper plasmid (pF∆6) and equal amounts of both AAV1 
(pH21) and AAV2 (pRV1) helper plasmids. Cells were harvested sixty hours 
following transfection and vectors were purified using heparin affinity columns 
(HiTrap Heparin HP; Amersham Pharmacia Biotech, Uppsala, Sweden). 
Quantitative PCR (SYBR-Green; Lightcycler™, Roche Diagnostics) using 
primers derived from the WPRE sequence were used for genomic titration of viral 
vector preparations. For in vivo application, vectors were diluted in sterile PBS to 
a concentration of 2.5 × 108 vector genomes/µl. 
 
4.4 Stereotaxic surgery 
 
For AAV-treatment, 57 adult male C57Bl/6 mice (25–30 g, Charles River 
Laboratories, Sulzfeld, Germany) were randomly allocated to three groups of 
19 animals. Mice were anesthetized by i.p. injection of a mixture of ketamine (120 
mg/kg body weight; Pharmanovo, Hannover, Germany) and xylazine (Rompun, 
16 mg/kg body weight; Bayer, Leverkusen, Germany), and placed in a stereotaxic 
frame (David Kopf Instruments, Tujunga, CA) before receiving bilateral infusions 
of 1.5 µl vector solution at a flow rate of 150 nl/min through a 35G stainless steel 
beveled NanoFil needle (WPI, Berlin, Germany). Coordinates for hippocampal 
injection were (relative to bregma): RC -2.0 mm, ML ±2.0 mm, DV -2.0 mm. 
Following infusion, needles were left in place for 2 min to allow fluid distribution 
away from the injection site depot. After surgery, mice were left in their home 
cages for 3 weeks to allow AAV-mediated transgene expression to reach stable 
peak levels. 
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4.5 Behavioural testing 
 
4.5.1 Open field 
Locomotor activity was measured in an open field arena (40x40x40 cm) made of 
white melamine resin-coated wooden board. The arena was located in a dedicated 
testing cubicle and was homogeneously illuminated at lux intensities well below 
aversive levels. Animals were entered into the center of the arena and allowed to 
freely explore for 30 min. Movement was recorded with a top-mounted video 
camera, and analyzed using proprietary high-resolution tracking software 
(SYGNIS tracker v4.1.4). Analysis was based on both a virtual grid subdividing 
the arena into 25 squares of 64 cm² each and a circle with radius r = 12 cm around 
the center of the arena. Total distance travelled and time spent in the circular 
center and the four corner squares of the open field were recorded. 
 
4.5.2 Active place avoidance 
The active place avoidance apparatus (Serrano et al., 2008) was located in a 
testing cubicle with visual cues on the inside walls. It consisted of a slowly 
rotating (1 rpm), circular platform (radius r = 40 cm) surrounded by a transparent 
wall. One randomly chosen 60° sector of the arena was designated as the 
non-rotating shock zone where animals received a mild 0.4 mA electric shock 
upon entry, and further identical shocks every 1.5 s if they failed to leave the 
sector. The shock zone was identical for all animals and its location only 
identifiable relative to the extra-maze visual cues. Due to platform rotation, any 
passive strategy was inevitably associated with foot-shocks, and animals quickly 
learned to actively avoid the shock zone. After a 10 min pre-training trial without 
shocks, 8 training trials of 10 min each were conducted at inter-trial intervals of 
12 min which animals spent in their home cages. After 24 hours, one retention 
trial was run without triggering foot shocks. Latency to shock zone entry was 
recorded during all trials. 
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4.5.3 Fear conditioning 
Mice were placed in a conditioning chamber with transparent walls and a stainless 
steel grid rod floor which was set up inside a sound attenuating cubicle containing 
an exhaust fan as a source of white noise and a video camera connected to video 
tracking software (Med Associates Inc, St. Albans, Vermont) recording animals’ 
locomotive behaviour. The chamber was thoroughly cleaned after every animal. 
For conditioning, mice spent 6 min inside the chamber under dim illumination 
with visible light, and were exposed to an acoustic signal (5 kHz, 85 dB, 30 s) at 
90-120 s, 150-180 s, 210-240 s, and 270-300 s (conditioned stimulus, CS). At the 
last second of each tone segment, one foot shock (0.6 mA, 1 s) was applied via the 
floor grid (unconditioned stimulus, US). Freezing was defined as a change in less 
than 11 out of 76800 pixels between two adjacent frames (33 ms apart) over a 
time period of at least 1 s. After 24 hours, animals were re-introduced to the 
chamber for 6 min in the absence of CS or US to evaluate contextual fear 
memory. 48 hours after training, cue-related fear memory was assessed. To hinder 
recognition of the chamber from haptic, olfactory, or visual cues the chamber was 
remodelled with a flat plastic floor panel covering the steel grid and a black roof-
shaped insert, by replacement of visible light with near infrared illumination, and 
by use of a different disinfectant for cleaning. Mice were exposed to this altered 
context for 4 min during which the 30 s CS was presented twice, terminating at 60 
and 180 s. Locomotive behaviour was analyzed as before. 
 
4.5.4 Morris water maze 
A circular pool (170 cm in diameter) was filled with opaque water (24 ± 1 °C) to a 
height of 35 cm with a circular escape platform (10 cm in diameter) submerged 
1 cm below the water surface at a constant position in the center of the North-
West (NW) quadrant during training. The pool openly faced the testing room 
which provided ample distal cues for visual spatial navigation. Mice were 
habituated to the maze 24 hours prior to training by a session of 4 trials in which 
the platform was located once in every quadrant. Here, the platform was visible 
by both elevation above water level and marking by a coloured mesh cage 
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structure. Training consisted of 4 daily trials on 11 (AAV animals) or 12 (GMko 
animals) consecutive days with inter-trial intervals (ITI) of 90 min. Cages were 
placed under infra-red lamps during the first 45 min of the ITI to prevent 
hypothermia. Animals were introduced into the pool from start positions East (E), 
South-East (SE), South (S), and South-West (SW) to avoid close initial proximity 
to the platform. Starting positions were block-randomized with 4 different starting 
positions in random order on every day. After successfully mounting the platform, 
animals were left there for 15 s. Cut-off time for trials was set to 60 s, after which 
animals failing to locate the platform were guided with a wooden rod and also left 
there for 15 s. Abandoning the platform during these 15 s was considered a 
platform jump-off. One probe trial of 120 s with the platform removed from the 
pool was conducted 24 hours after the last training day. Here, animals entered the 
pool from position S. On the following day, a cued platform test was conducted to 
rule out gross visual deficits. This test was similar to the pre-training session 
except that the pool was shielded from all extra-maze cues by black curtains to 
prevent animals from adopting previously learned search strategies. For GMko 
analysis, an additional 5-day reversal learning protocol started 48 hours later. 
Here, all positions were inverted compared to the former setup, i.e. platform now 
at SE and starting points pseudorandomized between W, NW, N, and NE. 
Frequency density maps were generated by accumulative addition of tracked 
trajectories (1 pixel wide) such that pixel density was analyzed in blocks of 5x5 
pixels and normalized to performance of wildtypes at the last training day. 
 
4.5.5 Rotarod 
Animals were tested for motor function on a rotarod (Ugo Basile, Comerio, Italy) 
on 6 consecutive days with 5 daily trials at ITIs of 8 min using a challenging 
protocol with constant acceleration (4-80 rpm in 300 s). Latencies to falling off 
the rod were recorded. In the rare event of an animal clinging to the rod and 
passively rotating with it for at least 10 s, time of onset of this behaviour was 
recorded as latency. 
 
MATERIALS AND METHODS 
 
81 
4.5.6 Dark-light box 
The dark-light test was conducted in a white 42x42x33 cm open field, of which 
the center of one side was linked at floor level by a door (8.5 x 10 cm) to a black 
21x42x33 cm compartment that was covered with a lid to keep it dark. The open 
field was brightly illuminated from above to provide 120 lx in the center and 95 lx 
at the junction door. The whole apparatus was located in a dedicated testing 
cubicle and was monitored by an overhead-mounted video camera. Mice were 
placed into the dark compartment for a 60 s habituation period with the exit 
closed. After that, the door was opened and animals were left to freely explore for 
330 s. For every animal, the following parameters were recorded: Time spent and 
number of rearings in the lit compartment. Presence in lit compartment required 
all four paws to be placed in the lit compartment. 
 
4.5.7 Plantar pain test 
Plantar pain threshold of rear paws was assessed by the Hargreaves method using 
an apparatus (Cat. Nr 7371, Ugo Basile, Comerio, Italy) to measure the response 
to infrared (IR) heat stimuli applied with an IR emitter over 5 trials with ITIs of 
10 min through the plastic floor of the test box. Mice were tested between 2 and 
6:30 h PM at an IR intensity of approximately 220 mW/cm². Because this test 
required animals to keep their hind paws motionless on the ground, habituation to 
the test chamber was allowed for at least 15 min. Care was taken to only test 
animals in alert, yet immobile states with dry paws. If an initiated trial was 
interrupted by grooming or locomotion-related paw movement, the trial was 
re-started no earlier than 10 min later to allow for the reversal of any pain 
sensitization triggered during the failed attempt. 
 
4.5.8 Spontaneous behaviour assessment by LABORAS 
The Laboratory Animal Behaviour Observation, Registration and Analysis 
System (LABORAS, Metris, Hoofddorp, Netherlands) is a fully automated system 
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for the vibration and force pattern-based detection and discrimination of a variety 
of rodent behaviours including locomotion, immobility, and cage climbing. Mice 
were individually placed in LABORAS cages at 6:00 h PM and spontaneous 
behaviour was monitored for 12 hours starting at 7:00 h PM. 
 
4.6 Hippocampal anatomy 
 
After deep anaesthesia, GMko and wildtype mice (n=6 per group) were 
transcardially perfused with phosphate buffered saline followed by 4 % 
paraformaldehyde. Brains were removed, embedded in paraffin and cut on a 
microtom to 10 µm coronal sections of which three consecutive slices were 
mounted to the same microscope slide. Starting with the slide carrying the 
rostralmost hippocampal section, every 10th slide was subjected to Masson’s 
Trichrom staining (Sigma Aldrich, Steinheim, Germany) such that always 9 slides 
(27 sections) were skipped. Stained sections were compared to a mouse brain atlas 
(Paxinos and Franklin, 2004) to exclude those from further analysis that were not 
covered by maps #42-#61 (i.e. bregma -1.34 mm to -3.64 mm). Sections were 
scanned and hippocampal areas were determined using ImageJ software 
(Rasband, 1997-2011). From these values hippocampal volumes were calculated 
by the Cavalieri method using equation V = ∑(A1, A2, …, An) * d, where 
V = hippocampal volume, Ax = mean hippocampal area of three sections on slide 
x, and d = distance between sections on consecutive slides (270 µm). 
Next, sections were subdivided into five groups (G1-G5) of rostral (G1), 
rostromedial (G2), medial (G3), mediocaudal (G4), and caudal (G5) location 
covering four atlas maps each with a rostrocaudal extent of 0.36 to 0.4 mm per 
group. Within these groups, lengths of distances D1-D5 between characteristic 
hippocampal structures were determined. These were defined as follows: 
D1 = maximal interhemispheric distance between CA3 pyramidal cell nuclei; 
D2 = distance between dorsal tips of DG granule cell and CA1 pyramidal cell 
layers; D3 = distance between ends of CA cell layer (CA1-CA3); D4 = distance 
between open ends of DG upper and lower blades; D5 = distance between CA1 
end of CA cell layer and junction of DG upper and lower blades. However, D1 
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and D2 were only determined on the one section per animal in which hippocampal 
width was maximal and no CA3 pyramidal cell nuclei lay ventral relative to DG 
granule cell nuclei. 
 
4.7 Neuronal morphology and dendritic spine analysis 
 
Brains were removed from deeply anesthetized animals and subjected to Golgi-
Cox staining using the FD Rapid GolgiStain kit (FD NeuroTechnologies, Ellicott 
City, USA) according to manufacturer’s instructions. Tissue was cut on a cryostat 
into 100 µm sections and confocal microscopic image acquisition was performed 
with a Leica TCS SP5 laser scanning microscope (Leica Microsystems, Wetzlar, 
Germany). For whole neuron reconstruction, stacks of images (step size 0.5 µm) 
were taken from individual DG granule cells and used for manual reconstruction 
with the Neuromantic software v1.6.3. Spine analysis was conducted on both CA1 
pyramidal and DG granule cells. Here, stacks of images (step size 0.2 µm) were 
taken of the first dendritic bifurcation in either stratum radiatum (CA1) or stratum 
moleculare (DG), and analysis was done from this bifurcation onwards to the 
distal end of the neurite, either until the neurite ended or disappeared from the 
display window, or the next bifurcation appeared. 
 
4.8 Electrophysiology 
 
All electrophysiological recordings were performed at the Interdisciplinary Center 
for Neurosciences in the group of Prof. Dr. Draguhn by Dr. Martin Both and 
Simon A. Kranig. Experiments were performed on 24 mice aged 6-10 weeks by 
experimenters blinded to genotype. Animals were anesthetized with CO2, 
decapitated and brains removed. Brains were kept in cooled (1-4°C) artificial 
cerebrospinal fluid (ACSF), containing (mM): NaCl 124, KCl 3, MgSO4 1.8, 
CaCl2 1.6, glucose 10, NaH2PO4 1.25, NaHCO3 26, saturated with 
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95% O2 / 5% CO2 with a pH of 7.4 at 35°C. After removal of the cerebellum and 
frontal brain structures, horizontal hippocampal slices (450 µm) were cut on a 
vibratome (Leica, VT 1000S, Germany). Slices were maintained at 35 ± 0.5°C in 
a Haas-type interface chamber and rested for ≥ 2.5 hours prior to experiments. 
Extracellular glass microelectrodes (tip diameter ~5 µm) filled with ACSF were 
placed in CA1 str. pyramidale and str. radiatum. Electrical stimulation to Schaffer 
collaterals was achieved by a bipolar platinum / iridium electrode (Science 
Products, 100 kΩ at 1 kHz, 75 µm tip distance). Stimulation strength was adjusted 
to evoke population spikes with 50 % of the maximal amplitude. Test pulses were 
applied every 30 s.  LTP was induced by a delta burst protocol (consisting of 10 
bursts within 8 s, each at 100 Hz with 40 ms duration). If baseline recording was 
stable over ≥ 20 min, potentials were amplified 100-fold, low pass-filtered at 
10 kHz, high pass-filtered at 0.3 Hz (EXT10-2FX amplifiers, npi electronics, 
Tamm, Germany), digitized at 20 kHz for offline analysis (1401 interface and 
Spike-2 data acquisition program, CED, Cambridge, UK), and analyzed offline 
using custom routines written in Matlab (The MathWorks, Natick, MA).  
 
4.9 Neurite outgrowth analysis 
 
Primary hippocampal neurons were prepared from E18.5 rat embryos and seeded 
on coverslips in 24-well plates at a density of 10000 cells per well. Six hours after 
seeding, GM-CSF or vehicle was added and neurons were fixed with 
4 % paraformaldehyde 48 hours after stimulation. Cells were stained for 
neurofilament-L (AB9568, 1:200, Millipore, Schwalbach, Germany) in 
1 % BSA / TBS o/n at 4°C. FITC-labelled secondary antibody was applied for 1 h 
at room temperature in 0.1 % BSA / TBS (1:200, Dianova, Hamburg, Germany). 
Image acquisition at 40x magnification was done in a grid of 7x7 pictures to yield 
composits of 49 individual images covering a total area of 1.8 mm². Each 
composit was screened in a predefined pattern by a blinded observer for fully 
traceable neurons, and total neurite length per cell was determined using the 
NeuronJ plug-in for ImageJ. A maximum of 15 neurons was traced per coverslip 
to ultimately yield 100 neurons per group. 
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4.10 Csf2ra targeting vector construction 
 
The targeting vector was based on BAC clone 367J9 from the bMQ library 
generated from murine AB2.2 ES cell DNA. This library covers > 99 % of all 
Ensembl genes at 3.6-fold autosome coverage and an average insert size of 
110.7 kb (Adams et al., 2005). The vector was constructed using both 
conventional cloning and Red/ET recombineering (Zhang et al., 1998; Zhang et 
al., 2000). Both loxP sites were introduced by Red/ET recombineering using 
commercially available kits (Cat. No. K005, Gene Bridges GmbH, Heidelberg, 
Germany). The 373 bp intronic splice acceptor sequence was PCR-amplified from 
bMQ367J9 (nucleotides 35296-35668) using the following primers: intron_s, 
5’-CTGTCAGTCAGATGAGTGGGCAGAG-3’ and intron_as, 
5’-CCACTTAGCTGGtgaatgaatgaaGCTGAGCTTGGAGCACGGCGGGGTT-3’.
The eYFP-ORF was amplified from pDEST-N-eYFP using primers eYFP_s 
5’-cccactcatctgactgacagATGGTGAGCAAGGGCGAGGAGCTGT-3’ and 
eYFP_as 5’-ccagctaagtggACAAACCACAACTAGAATGCAGTGA-3’. Both 
amplicons were used as templates in a 2-fragment PCR approach using primers 
sa-eYFP_s: 5’-ccagctaagtggACAAACCACAACTAGAATG-3’ and sa-eYFP_as: 
5’-ccacttagctggTGAATGAATGAAGCTGAGC-3’, thus generating a 
BstXI-flanked splice acceptor-eYFP fusion fragment with upstream stop codons 
in all frames. This cassette was subsequently subcloned to the BAC using a 
BstXI-compatible artificial I-CeuI recognition sequence. The herpes simplex virus 
thymidine kinase (HSVtk) ORF was BamHI x ClaI-isolated from plasmid 
pIC19R_MC1-tk and subcloned into the targeting vector which was transferred 
prior to that to a plasmid backbone by Red/ET  recombineering  (Cat. No. K003, 
Gene Bridges GmbH, Heidelberg, Germany). Subsequently, FRT sites were 
introduced flanking the downstream neo cassette by PCR in a stretch of sequences 
located between unique PmeI / NheI restriction sites. These sites were used to 
exchange the non-FRT by the FRT-flanked cassette. The targeting vector was 
linearized by an artificial SbfI site introduced adjacent to the HSVtk gene prior to 
ES cell transfection. 
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4.11 Embryonic stem cells 
 
PluriStem 129/SvEv (S6) murine ES cells (Millipore GmbH, Schwalbach, 
Germany) were used for generation of the Csf2ra conditional knock-out mouse 
line. ES cells were grown on mitomycin C-treated primary mouse embryonic 
feeder cells (Millipore GmbH, Schwalbach, Germany) in serum-containing 
EmbryoMax medium from the same manufacturer. 
 
4.12 Statistics 
 
Comparisons between two conditions were made with the two-sided t-test. More 
conditions were analyzed using ANOVA with a post-hoc Tukey-Kramer test. 
Serial tests were analyzed using regression analysis. In addition, AUC analyses 
were performed. A p-value of < 0.05 was considered significant for all tests. All 
analyses were performed using JMP v8.02 (SAS Institute). 
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6 LIST OF ABBREVIATIONS 
 
Å  Angström 
AAV  adeno-associated virus 
AAVS1 AAV integration site 1 
ACSF  artificial cerebrospinal fluid 
AD  Alzheimer’s disease 
ANOVA analysis of variance 
APA  active place avoidance 
Aβ  amyloid beta 
BAC bacterial artificial chromosome 
BAD Bcl-2 associated death promoter 
Bcl-2  B-cell lymphoma 2 
BDNF brain derived neurotrophic 
factor 
bGHpA bovine growth hormone 
polyadenylation signal 
bp  base pair 
BSA  bovine serum albumin 
CA  cornu ammonis 
cAMP cyclic adenosine monophosphate 
CBA  chicken beta actin 
cDNA  complementary DNA 
CNS  central nervous system 
CRE  cAMP response element 
Cre  Causes recombination 
CREB  cAMP response element binding   
  protein 
CRM  cytokine receptor module 
CS  conditioned stimulus 
Csf2ra alpha subunit of the GM-CSFR 
Cy3  cyanine-3 
DG  dentate gyrus 
DNA  deoxyribonucleic acid 
dsDNA double stranded DNA 
DV  dorso-ventral axis 
E18.5  embryonic day 18.5 
EC  entorhinal cortex 
eGFP enhanced green fluorescent 
protein 
EPO  erythropoietin 
EPOR  erythropoietin receptor 
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EPSP excitatory postsynaptic potential 
ERK  extracellular signal-regulated  
  kinase 
ES cell embryonic stem cell 
eYFP  enhanced yellow fluorescent protein 
FC  fear conditioning 
FITC  fluorescein isothiocyanate 
FNIII  fibronectin III 
GABA γ-aminobutyric acid 
G-CSF granulocyte colony stimulating 
factor 
G-CSFR G-CSF receptor 
GFP  green fluorescent protein 
GM-CSF granulocyte/macrophage colony 
stimulating factor 
GM-CSFR GM-CSF receptor 
GM-CSFRα alpha subunit of the GM-CSFR 
GMko  GM-CSF knock-out 
Grb2 growth factor receptor-bound 
protein 2 
GTP  gunaosine-5’-triphosphate 
HEK  human embryonic kidney 
hrGFP humanized renilla GFP 
HSD  honestly significant difference 
HSVtk herpes simplex virus thymidin 
kinase 
IκB  inhibitor of kappa B 
IKK  IκB kinase 
IL  interleukin 
IRES  internal ribosome entry site 
ITI  inter-trial interval 
ITR  inverted terminal repeat 
JAK  Janus kinase 
JMML juvenile myelomonocytic 
leukemia 
JNK  c-Jun N-terminal kinase 
Kb  kilobases 
KD  dissociation constant 
loxP locus of crossover in phage P1 
LPP  lateral perforant path 
LTP  long-term potentiation 
Lx  lux 
MAPK mitogen-activated protein kinase 
ML  medio-lateral axis 
mM  millimolar 
MPP  medial perforant path 
MPTP 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine 
mRNA messenger ribonucleic acid 
MTL  medial temporal lobe 
MWM Morris water maze 
neoR  neomycin resistance 
NFkB nuclear factor kappa-light-chain 
enhancer of activated B cells  
NMDA N-Methyl-D-aspartate 
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NR1  NMDA receptor subunit 1 
NR2  NMDA receptor subunit 2 
NSC34 neuroblastoma × spinal cord 
hybrid cell line 
ORF  open reading frame 
PAP pulmonary alveolar proteinosis 
PBS  phosphate-buffered saline 
PCR  polymerase chain reaction 
PDK1 3-phosphoinositide dependent 
protein kinase-1 
PH  pleckstrin homology 
PI3K  phosphoinositide3-kinase 
PIP2 Phosphatidylinositol 4,5-
bisphosphate 
PIP3 Phosphatidylinositol (3,4,5)-
triphosphate 
PKC  protein kinase C 
pM  picomolar 
PP  perforant path 
RA  rheumatoid arthritis 
rAAV  recombinant AAV 
RC  rostro-caudal axis 
REM  rapid eye movement 
rGM-CSF recombinant GM-CSF 
RNA  ribonucleic acid 
RNAi  RNA interference 
 
 
rpm  revolutions per minute 
RSK  p90 ribosomal S6 kinase 
s.e.m.  standard error of the mean 
S6K  p70 ribosomal S6 kinase 
SAPK  stress-activated protein kinase 
SCI  spinal cord injury 
SGK  glucocorticoid-induced protein  
  kinase 
Shc  Src homology 2 domain   
  containing protein 
shRNA small hairpin RNA 
ssDNA single-stranded DNA 
STAT  signal transducer and activator of 
  transcription 
str.  stratum 
TBS  TRIS-buffered saline 
TRIS  Tris(hydroxymethyl)-aminomethan 
UNC  universal negative control 
US  unconditioned stimulus 
UTR  untranslated region 
WPRE woodchuck hepatitis virus 
post-transcriptional regulatory 
element 
wt  wildtype 
βc  common beta subunit 
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